file_id,presid,url,time,title,presenter
266,1439201,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1439201&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM2,1:00 PM – 1:35 PM US PT,Introduction and Principles of Diagnosis Excellence & Diagnostic Stewardship,
266,1436678,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1436678&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM2,1:35 PM – 2:00 PM US PT,What Clinicians Should Know About the Lab and What Laboratory Professionals Should Know About Diagnostic Stewardship,
266,1436679,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1436679&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM2,2:00 PM – 2:40 PM US PT,Interactive Panel: Moderated by Mary Hayden,
266,1436680,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1436680&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM2,2:55 PM – 3:20 PM US PT,Common First Targets for Diagnostic Stewardship,
266,1436683,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1436683&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM2,3:20 PM – 3:45 PM US PT,"Stewarding Advanced Diagnostics: Multiplex Panels, Metagenomics and Beyond",
266,1436684,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1436684&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM2,3:45 PM – 4:10 PM US PT,Core Elements for Diagnostic Excellence,
266,1436685,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1436685&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM2,4:10 PM – 4:50 PM US PT,Interactive Panel: Moderated by Dan Diekema,
268,1408110,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408110&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,8:00 AM – 8:10 AM US PT,Introductory Remarks,N/A
268,1408109,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408109&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,8:10 AM – 8:45 AM US PT,Sexually Transmitted Infections,
268,1408108,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408108&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,8:45 AM – 9:20 AM US PT,Mycobacteria Including TB,
268,1407338,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407338&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,9:20 AM – 9:55 AM US PT,Fungal Infections,
268,1408107,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408107&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,10:10 AM – 10:45 AM US PT,ID Therapeutics: A Broad Overview,
268,1408106,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408106&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,10:45 AM – 11:20 AM US PT,Bacterial Syndrome Pearls,
268,1408103,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408103&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,11:20 AM – 11:45 AM US PT,Infection Prevention Update,
268,1408114,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408114&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,1:00 PM – 1:35 PM US PT,ID Mimics: Noninfectious Causes of Elevated Temperature,
268,1408104,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408104&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,1:35 PM – 2:10 PM US PT,Brain Teasers:  Nervous System Infections and Mimics,
268,1408105,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408105&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,2:10 PM – 2:45 PM US PT,Transplant Infections,
268,1408100,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408100&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,3:00 PM – 3:35 PM US PT,HIV,
268,1408102,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408102&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,3:35 PM – 4:10 PM US PT,Parasitic Diseases,
268,1408099,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408099&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,4:10 PM – 4:45 PM US PT,Viral Diseases,
268,1407340,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407340&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,4:45 PM – 5:20 PM US PT,Vector-Borne Infections,
268,1408101,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408101&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDAyMDM1,5:20 PM – 5:30 PM US PT,Closing Remarks and Questions,N/A
269,1484888,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1484888&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDk1MzI0,8:00 AM – 8:10 AM US PT,Introduction and Workshop Overview,
269,1424116,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424116&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDk1MzI0,8:10 AM – 9:00 AM US PT,Stewarding Bone and Joint Infections,
269,1424118,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424118&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDk1MzI0,9:05 AM – 10:00 AM US PT,Tele-Antimicrobial Stewardship Panel,
269,1424119,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424119&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDk1MzI0,10:05 AM – 10:25 AM US PT,How to Disagree Better Using Advocacy-Inquiry to Improve Communication With Clinicians,
269,1424120,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424120&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDk1MzI0,10:30 AM – 11:00 AM US PT,Using Conversation Research to Improve Communication With Patients,
269,1424121,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424121&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDk1MzI0,11:05 AM – 11:55 AM US PT,Pro/Con Debate Is ESBL Testing Necessary for Ceftriaxone-Resistant Enterobacterales?,
271,1407871,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407871&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjg5,1:30 PM – 2:05 PM US PT,The gut microbiota of cancer patients as predictor of complications and outcomes,
271,1407873,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407873&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjg5,2:05 PM – 2:40 PM US PT,The role of the mycobiome in hematopoietic cell transplantation outcomes,
271,1407872,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407872&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjg5,2:40 PM – 3:15 PM US PT,"Diet, mucus and microbiome in cancer-related neutropenic fever",
272,1407883,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407883&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5ODAz,1:30 PM – 1:55 PM US PT,Wastewater surveillance to direct public health action,
272,1407881,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407881&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5ODAz,1:55 PM – 2:20 PM US PT,Using wastewater to track diseases with limited public health surveillance data,
272,1407882,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407882&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5ODAz,2:20 PM – 2:45 PM US PT,Leveraging wastewater surveillance for respiratory virus infection response in healthcare facilities,
272,1407880,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407880&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5ODAz,2:45 PM – 3:15 PM US PT,From Toilet to Bedside: How Wastewater Surveillance Can Be Leveraged For Clinical Consideration,
273,1407923,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407923&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzY5,1:30 PM – 2:05 PM US PT,Malaria Transmission: What are the Plasmodium secrets?,
273,1407922,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407922&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzY5,2:05 PM – 2:40 PM US PT,Impact of Climate Change in the Immune Defense against Candida,
273,1407921,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407921&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzY5,2:40 PM – 3:15 PM US PT,Leishmania immunopathology and climate impact on Leishmaniasis,
274,1407979,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407979&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzk3,1:30 PM – 2:05 PM US PT,Bundles and beyond: What works and doesn’t work in improving sepsis outcomes,
274,1407977,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407977&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzk3,2:40 PM – 3:15 PM US PT,Getting off the sidelines: Promoting ID leadership in sepsis care,
276,1408122,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408122&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzc4,1:30 PM – 1:55 PM US PT,What's Hot in HIV Basic Sciences,
276,1408121,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408121&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzc4,1:55 PM – 2:20 PM US PT,What's Hot in HIV: Clinical Sciences,
276,1408120,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408120&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzc4,2:20 PM – 2:45 PM US PT,What's Hot in ID Basic Sciences,
276,1408123,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408123&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzc4,2:45 PM – 3:15 PM US PT,What's Hot in ID Clinical Sciences,
277,1408010,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408010&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjc0,1:30 PM – 1:48 PM US PT,Amoxicillin should be used as first line treatment of acute sinusitis,
277,1408007,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408007&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjc0,1:48 PM – 2:05 PM US PT,Amoxicillin-clavulanate should be used as first line treatment of acute sinusitis,
277,1408009,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408009&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjc0,2:05 PM – 2:20 PM US PT,Contact isolation should be used for patients with CTX-R/ESBL producing Enterobacterales,
277,1408008,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408008&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjc0,2:20 PM – 2:40 PM US PT,Contact isolation is not necessary for patients with CTX-R/ESBL producing Enterobacterales,
277,1408006,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408006&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjc0,2:40 PM – 2:57 PM US PT,Plasma microbial cell-free DNA sequencing should be routinely used as a diagnostic test in the ID clinician’s tool kit,
277,1408005,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408005&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjc0,2:57 PM – 3:15 PM US PT,Plasma microbial cell-free DNA sequencing should be rarely if ever be used as a diagnostic test in the ID clinician’s tool kit,
280,1483000,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1483000&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzc5,3:45 PM – 4:15 PM US PT,Awards Presentation,N/A
280,1483003,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1483003&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzc5,4:15 PM – 4:30 PM US PT,Presentation #1,
280,1483005,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1483005&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzc5,4:30 PM – 4:45 PM US PT,Presentation #2,
280,1483007,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1483007&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzc5,4:45 PM – 5:00 PM US PT,Presentation #3,
280,1483008,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1483008&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzc5,5:00 PM – 5:30 PM US PT,Panel Discussion,
283,1491605,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491605&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,8:00 AM – 1:00 PM US PT,Pediatric Case #1,
283,1491604,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491604&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,8:00 AM – 1:00 PM US PT,Pediatric Case #2,
283,1491603,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491603&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,8:00 AM – 1:00 PM US PT,Pediatric Case #3,
283,1491602,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491602&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,8:00 AM – 1:00 PM US PT,Pediatric Case #4,
283,1491601,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491601&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,8:00 AM – 1:00 PM US PT,Pediatric Case #5,
283,1491600,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491600&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,8:00 AM – 1:00 PM US PT,Pediatric Case #6,
283,1424209,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424209&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,8:00 AM – 8:10 AM US PT,Welcome,N/A
283,1424174,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424174&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,8:10 AM – 10:00 AM US PT,Case Presentations,N/A
283,1424175,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424175&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,10:00 AM – 10:40 AM US PT,Career Talk,
283,1424139,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424139&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,10:55 AM – 12:10 PM US PT,ASP Breakout,
283,1424177,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424177&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,10:55 AM – 12:10 PM US PT,Basic/Translational Research Breakout,
283,1424176,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424176&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,10:55 AM – 12:10 PM US PT,Global Health Breakout,
283,1475055,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1475055&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,10:55 AM – 12:10 PM US PT,IMG Breakout,
283,1424179,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424179&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,10:55 AM – 12:10 PM US PT,QI/ Patient Safety Breakout,
283,1424178,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424178&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI2,10:55 AM – 12:10 PM US PT,Transplant Breakout,
285,1424185,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424185&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI3,8:00 AM – 8:05 AM US PT,Introductory Remarks,
285,1424180,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424180&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI3,8:05 AM – 8:25 AM US PT,TB Epidemiology Overview in the US and Globally,
285,1424181,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424181&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI3,8:25 AM – 8:45 AM US PT,BPaL Relapse With Resistance,
285,1424184,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424184&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI3,8:45 AM – 9:00 AM US PT,Final Rule on LDTs,
285,1461274,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1461274&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI3,9:00 AM – 9:15 AM US PT,Break,N/A
285,1424182,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424182&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI3,9:15 AM – 9:35 AM US PT,We don't have what our patients need: resource limitations in providing care for people with TB in the United States,
285,1424183,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424183&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI3,9:35 AM – 9:55 AM US PT,Non-sputum diagnostics & Diagnostics Pipeline,
285,1461254,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1461254&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI3,9:55 AM – 10:15 AM US PT,TB in Pregnancy,
285,1424186,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424186&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0NDI3,10:30 AM – 12:00 PM US PT,Clinical Case Studies & Panel Discussion,
286,1424122,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424122&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDk1MzI1,8:00 AM – 8:05 AM US PT,Introduction and workshop overview,
286,1424133,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424133&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDk1MzI1,8:05 AM – 8:30 AM US PT,"Outpatient Antibiotic Use, the Core Elements of Outpatient Antibiotic Stewardship and National Stewardship Priorities",
286,1424135,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424135&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDk1MzI1,8:30 AM – 9:15 AM US PT,Antibiotic Stewardship Metrics in the Outpatient Space,
286,1462083,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1462083&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDk1MzI1,9:15 AM – 9:30 AM US PT,Q&A,N/A
286,1424136,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424136&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDk1MzI1,9:30 AM – 10:30 AM US PT,"Making the Case for Outpatient Stewardship: Who, Why and How?",
286,1424137,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424137&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDk1MzI1,10:45 AM – 12:00 PM US PT,Collaborations in Outpatient Stewardship,
287,1424108,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424108&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MzU4,8:00 AM – 8:05 AM US PT,Welcome,
287,1480014,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1480014&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MzU4,8:05 AM – 8:50 AM US PT,Clinical Updates in Orthopedic ID for APPs,
287,1424110,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424110&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MzU4,8:50 AM – 9:40 AM US PT,"Clinical Updates in Infective Endocarditis Presentation, Diagnosis, and Treatment for APPs",
287,1424111,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424111&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MzU4,9:50 AM – 10:40 AM US PT,Clinical Topics in General ID,
287,1424112,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424112&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MzU4,10:40 AM – 11:30 AM US PT,Antibiotics Overview,
287,1424113,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424113&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MzU4,11:30 AM – 11:50 AM US PT,OPAT Overview for APPs,
287,1480013,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1480013&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MzU4,11:50 AM – 12:00 PM US PT,Q&A,
289,1423731,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423731&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MzU5,8:00 AM – 8:10 AM US PT,Introduction to Curriculum Development,
289,1423735,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423735&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MzU5,8:10 AM – 9:00 AM US PT,Problem Identification and Needs Assessment,
289,1423734,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423734&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MzU5,9:05 AM – 9:50 AM US PT,Creating Goals and Objectives,
289,1423737,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423737&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MzU5,10:00 AM – 10:15 AM US PT,Educational Strategies and Implementation,
289,1423749,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423749&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MzU5,10:20 AM – 11:05 AM US PT,Implementation,
289,1424029,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424029&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MzU5,11:55 AM – 12:00 PM US PT,Report Out/Wrap-Up,
290,1491599,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491599&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,8:00 AM – 12:15 PM US PT,Case Presentation #1,
290,1491611,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491611&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,8:00 AM – 12:15 PM US PT,Case Presentation #2,
290,1491610,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491610&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,8:00 AM – 12:15 PM US PT,Case Presentation #3,
290,1491609,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491609&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,8:00 AM – 12:15 PM US PT,Case Presentation #4,
290,1491608,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491608&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,8:00 AM – 12:15 PM US PT,Case Presentation #5,
290,1491607,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491607&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,8:00 AM – 12:15 PM US PT,Case Presentation #6,
290,1491606,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491606&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,8:00 AM – 12:15 PM US PT,Case Presentation #7,
290,1408135,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408135&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,8:00 AM – 9:55 AM US PT,Case Presentations,
290,1408134,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408134&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,10:05 AM – 10:45 AM US PT,Compensation & Negotiating Your First Contract,
290,1408133,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408133&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,10:45 AM – 11:05 AM US PT,Career Breakouts Intro,N/A
290,1408140,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408140&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,11:10 AM – 12:15 PM US PT,Careers in Antimicrobial Stewardship,
290,1408138,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408138&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,11:10 AM – 12:15 PM US PT,Careers in Clinical Practice,
290,1408137,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408137&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,11:10 AM – 12:15 PM US PT,Careers in Global Health,
290,1408136,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408136&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,11:10 AM – 12:15 PM US PT,Careers in Hospital Epi and Infection Control,
290,1408145,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408145&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,11:10 AM – 12:15 PM US PT,Careers in Industry,
290,1408143,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408143&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,11:10 AM – 12:15 PM US PT,Careers in Medical Education,
290,1408142,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408142&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,11:10 AM – 12:15 PM US PT,Careers in Public Health,
290,1408141,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408141&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,11:10 AM – 12:15 PM US PT,Careers in Research,
290,1408144,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408144&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,11:10 AM – 12:15 PM US PT,Careers in Transplant/Oncology ID,
290,1408139,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408139&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTM4,11:45 AM – 12:15 PM US PT,Career Breakouts Round 2,N/A
302,1439199,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1439199&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2MTYy,1:45 PM – 2:10 PM US PT,Ocular Fungal Infections,
302,1439200,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1439200&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2MTYy,2:10 PM – 2:35 PM US PT,Fungal Endocarditis: Diagnosis and Management,
302,1439198,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1439198&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2MTYy,2:35 PM – 3:00 PM US PT,Fungal Disease of The Urinary System,
303,1407917,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407917&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDM5,1:45 PM – 2:10 PM US PT,Vaccine confidence:It’s not just for kids!,
303,1407918,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407918&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDM5,2:10 PM – 2:35 PM US PT,2 for 1: Overcoming Misinformation to Improve Vaccination in Pregnancy,
303,1407916,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407916&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDM5,2:35 PM – 3:00 PM US PT,"Vaccines Law: Misinformation, and Experts",
304,1422781,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1422781&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDI0,1:45 PM – 2:10 PM US PT,Clinical Metagenomics: Current State & Opportunities,
304,1423265,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423265&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDI0,2:10 PM – 2:35 PM US PT,Clinical Metagenomics: Leveraging clinical impact,
304,1423264,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423264&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDI0,2:35 PM – 3:00 PM US PT,Clinical Metagenomics: Roadmap for the future,
305,1407967,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407967&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTU1,1:45 PM – 2:10 PM US PT,Spectrum and management of infectious diseases in newly resettled adults,
305,1407965,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407965&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTU1,2:10 PM – 2:35 PM US PT,Screening algorithms to identify latent and subclinical infections in newly resettled populations,
305,1407966,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407966&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTU1,2:35 PM – 3:00 PM US PT,Spectrum and management of infectious diseases in newly resettled children,
306,1407970,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407970&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjUw,1:45 PM – 2:10 PM US PT,Theory and Practice of Dissemination and Implementation Science in Infectious Diseases,
306,1407969,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407969&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjUw,2:10 PM – 2:35 PM US PT,Back to the Basics: Ensuring Infection Prevention Practices are Happening the Way They Should,
306,1407968,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407968&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjUw,2:35 PM – 3:00 PM US PT,Overcoming Barriers in the Implementation of Evidence-Based Strategies to Reduce the Risk of Surgical Site Infections,
307,1489410,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1489410&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDQw,1:45 PM – 2:10 PM US PT,Bridging the Treatment Gap: Estimating the Impact of Widespread Syphilis Point-of-Care Testing,
307,1489413,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1489413&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDQw,2:10 PM – 2:35 PM US PT,Can Doxy-PEP Implementation Reverse Syphilis Trends?,
307,1489412,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1489412&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDQw,2:35 PM – 3:00 PM US PT,Clinical Conundrums in Syphilis Management,
308,1408021,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408021&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyODE0,1:45 PM – 2:10 PM US PT,Obesity Dosing in Antibacterials,
308,1408020,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408020&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyODE0,2:10 PM – 2:35 PM US PT,Is More Better? Dosing of Antivirals in Patients with Obesity,
308,1408019,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408019&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyODE0,2:35 PM – 3:00 PM US PT,Antifungal Dosing for Patients with Obesity,
309,1408059,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408059&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2Mzc0,1:45 PM – 2:10 PM US PT,Approach to Bacterial Infections after Conflict Trauma and Burn Injuries,
309,1408058,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408058&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2Mzc0,2:10 PM – 2:35 PM US PT,Invasive Fungal Infections Following Military and Civilian Trauma,
309,1408057,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408057&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2Mzc0,2:35 PM – 3:00 PM US PT,Trauma on the Homefront:  Infections after Unique Pediatric Injuries,
310,1408062,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408062&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyOTQ3,1:45 PM – 2:10 PM US PT,HIV Prevention for Black Cis-Gender Women in the US,
310,1408061,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408061&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyOTQ3,2:10 PM – 2:35 PM US PT,Menopause and HIV Interactions,
310,1408060,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408060&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyOTQ3,2:35 PM – 3:00 PM US PT,Global HIV in Women and Children: Progress and Challenges,
311,1498426,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498426&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk4,1:45 PM – 2:00 PM US PT,,
311,1498422,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498422&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk4,2:00 PM – 2:15 PM US PT,,
311,1498418,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498418&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk4,2:15 PM – 2:30 PM US PT,A Quality Improvement Pilot to Increase Hepatitis B Screening and Optimize Patient Selection for Switch to Two-Drug Antiretroviral Regimens in Patients with HIV,
311,1498414,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498414&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk4,2:30 PM – 2:45 PM US PT,Long-Acting Injectable HIV Treatment in Individuals with Adherence Challenges: Real-World Insights from Southern California,
311,1498410,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498410&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk4,2:45 PM – 3:00 PM US PT,Hepatitis B Screening Among Persons With HIV Receiving Care from the U.S. Department of Veterans Affairs,
312,1498425,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498425&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAw,1:45 PM – 2:00 PM US PT,Transplant Transmitted Infectious Among Recipients of Drowned Donor Organs: A Six Year DTAC Experience,
312,1498421,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498421&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAw,2:00 PM – 2:15 PM US PT,RSV Pre-F IgG levels in pediatric hematopoietic stem cell transplant (HCT) and leukemia/lymphoma patients,
312,1498417,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498417&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAw,2:15 PM – 2:30 PM US PT,Prospective Study of Cytomegalovirus (CMV) Reactivation in Patients with Multiple Myeloma Receiving anti-CD38 and BCMA Therapies: An Interim Data Analysis,
312,1498413,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498413&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAw,2:30 PM – 2:45 PM US PT,"Comparison of Clinical Risk Factors, Outcomes and Molecular Epidemiology of ESBL and non-ESBL Enterobacterales Bacteremia in Solid Organ Transplant Recipients",
312,1498409,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498409&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAw,2:45 PM – 3:00 PM US PT,,
314,1498424,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498424&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk5,1:45 PM – 2:00 PM US PT,Intrapartum Antibiotic Exposure and Infectious Diseases in Childhood - A Population-based Cohort Study,
314,1498420,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498420&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk5,2:00 PM – 2:15 PM US PT,Retrospective Review of Management of Acute Otitis Media in a Canadian Pediatric Emergency Department,
314,1498416,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498416&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk5,2:15 PM – 2:30 PM US PT,Impact of 24/7 Rapid Diagnostic Testing Pharmacist Interventions and Infectious Diseases Consultation in Pediatric Bacteremia,
314,1498412,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498412&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk5,2:30 PM – 2:45 PM US PT,Identifying Opportunities for Urine Culture Diagnostic Stewardship in a Pediatric Health System,
314,1498408,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498408&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk5,2:45 PM – 3:00 PM US PT,Implementation of Methicillin Resistant Staphylococcus Aureus (MRSA) Nasal Polymerase Chain Reaction (PCR) Swabs in Pediatric Patients,
315,1498423,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498423&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk3,1:45 PM – 2:00 PM US PT,Concordance of UTI Antibiotic Treatments with Facility-Specific Antibiograms in Nursing Homes,
315,1498419,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498419&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk3,2:00 PM – 2:15 PM US PT,A Quality Improvement Endeavor to Improve Antibiotic Prescribing for Children with Acute Otitis Media in Emergency and Urgent Care Settings,
315,1498415,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498415&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk3,2:15 PM – 2:30 PM US PT,AMR-Informed Antibiotic Use Metrics,
315,1498411,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498411&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk3,2:30 PM – 2:45 PM US PT,Elevating Infectious Diseases Management: Impact of an Inpatient Pharmacist-Led Tele-Antimicrobial Stewardship Program Integrated within a Health System,
315,1498407,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498407&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk3,2:45 PM – 3:00 PM US PT,: A 92-Hospital Cluster Randomized Trial of telligent tewardship rompts to mprove eal-time mpiric Antibiotic Selection versus Routine Antibiotic Selection Practices for Patients with Skin and Soft Tissue Infections,
316,1491613,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491613&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA5ODA4,1:45 PM – 3:00 PM US PT,Case Presentation #1,
316,1491615,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491615&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA5ODA4,1:45 PM – 3:00 PM US PT,Case Presentation #2,
316,1491614,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491614&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA5ODA4,1:45 PM – 3:00 PM US PT,Case Presentation #3,
316,1491617,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491617&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA5ODA4,1:45 PM – 3:00 PM US PT,Case Presentation # 4,
316,1491616,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1491616&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA5ODA4,1:45 PM – 3:00 PM US PT,Case Presentation # 5,
319,1407915,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407915&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEwMTcw,3:15 PM – 3:50 PM US PT,TB After 3HP: Assessing the durability of TB prevention in a high-incidence island,
319,1407914,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407914&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEwMTcw,3:50 PM – 4:30 PM US PT,Less is More: Shortening TB Preventive Therapy,
320,1407932,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407932&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTcz,3:15 PM – 3:40 PM US PT,Epidemiology of Antimicrobial-Resistant Infections in North America and East Asia,
320,1407931,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407931&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTcz,3:40 PM – 4:05 PM US PT,Antimicrobial Treatment Guidelines and their Rationale in Japan,
320,1407930,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407930&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTcz,4:05 PM – 4:30 PM US PT,This is How we Do It: US Approach to Antimicrobial Stewardship Guidelines,
321,1407940,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407940&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTY2,3:15 PM – 3:40 PM US PT,Increasing Access to Novel Therapeutics in Public Health Emergencies,
321,1407941,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407941&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTY2,3:40 PM – 4:05 PM US PT,Public health efforts to improve hepatitis C care and treatment in Los Angeles,
321,1407939,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407939&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTY2,4:05 PM – 4:30 PM US PT,Controlling the regional spread of MDROs,
322,1407995,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407995&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTU4,3:15 PM – 3:40 PM US PT,"Let’s Get Real: Using Virtual and Extended Reality for Infection Prevention, Control Training and Education of Front Line Staff",
322,1407994,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407994&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTU4,3:40 PM – 4:05 PM US PT,Here’s a (VR) App for That: Addressing Human Factors via Headsets & Beyond,
322,1402361,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1402361&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTU4,4:05 PM – 4:30 PM US PT,Using VR to Teach IPC Foundations and Cleaning and Disinfection of Portable Medical Equipment,
323,1408068,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408068&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIxNzQ1,3:15 PM – 3:40 PM US PT,My Pathway: From a Summer Program to ID Faculty,
323,1408067,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408067&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIxNzQ1,3:40 PM – 4:05 PM US PT,Being INSPIREd: My Experience in an Undergraduate ID Summer Program,
323,1408066,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408066&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIxNzQ1,4:05 PM – 4:30 PM US PT,Preparing Diverse Students for Successful Careers in ID,
324,1408081,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408081&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyNzkz,3:15 PM – 3:40 PM US PT,Helping the Host before things Go Viral: Immunotherapy of Viral Infections,
324,1408080,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408080&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyNzkz,3:40 PM – 4:05 PM US PT,Immunotherapy for mycobacterial and fungal infections,
324,1408079,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408079&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyNzkz,4:05 PM – 4:30 PM US PT,Immunotherapy for bacterial infections,
325,1498405,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498405&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk1,3:15 PM – 3:30 PM US PT,Targeting Infection Prevention Efforts with Artificial Intelligence,
325,1498400,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498400&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk1,3:30 PM – 3:45 PM US PT,,
325,1498396,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498396&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk1,3:45 PM – 4:00 PM US PT,screening among asymptomatic carriers admitted for bone marrow transplantation: Navigating optimal stewardship strategies,
325,1498392,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498392&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk1,4:00 PM – 4:15 PM US PT,Utilization of the Four Themes of the CDC/ATSDR SVI Interactive Map in Assessing Initial Clostridioides difficile Infection Outcomes,
325,1498387,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498387&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk1,4:15 PM – 4:30 PM US PT,A Cluster Randomized Trial Evaluating Universal Gloving for Reducing Acquisition and Infection in VA: The GloRI Study,
326,1498404,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498404&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk0,3:15 PM – 3:30 PM US PT,Ex vivo Assessment of Cefepime (FEP) Clearance during Continuous Renal Replacement Therapy (CRRT) and Clinical Validation of Optimized Dosing Regimens,
326,1498399,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498399&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk0,3:30 PM – 3:45 PM US PT,Exposure-response relationship of ceftazidime/avibactam in adults with central nervous system infections caused by carbapenem-resistant a prospective observational study,
326,1498395,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498395&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk0,3:45 PM – 4:00 PM US PT,Population Pharmacokinetics of Meropenem-Vaborbactam in Acutely Ill Hospitalized Patients with Various Degrees of Renal Dysfunction,
326,1498391,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498391&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk0,4:00 PM – 4:15 PM US PT,Implementation of a Pharmacist Driven Beta-lactam Therapeutic Drug Monitoring Program with Daily Result Reporting: Initial Experiences and Challenges Faced,
326,1498386,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498386&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjk0,4:15 PM – 4:30 PM US PT,Defining Optimal Sampling Times for Cefepime Therapeutic Drug Monitoring in Clinical Practice,
327,1498406,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498406&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjky,3:15 PM – 3:27 PM US PT,Gonorrhea and Chlamydia Opt-Out Screening of Justice-Involved Females During Intake at the Los Angeles County Jail: The Pivotal Role of Correctional Health Systems,
327,1498401,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498401&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjky,3:27 PM – 3:39 PM US PT,Electronic Visit (E-visit) Use for Sexually Transmitted Infection (STI) Testing in a Large Integrated Healthcare System,
327,1498397,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498397&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjky,3:39 PM – 3:51 PM US PT,Clinical Characteristics and Outcomes of Patients Treated with Tecovirimat for Mpox Disease: A Large Cohort in New York City,
327,1498393,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498393&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjky,3:51 PM – 4:03 PM US PT,,
327,1498389,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498389&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjky,4:03 PM – 4:15 PM US PT,Effectiveness of JYNNEOS Vaccination in Preventing Lesion Dissemination Among Individuals with Confirmed Mpox Infection,
327,1498388,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498388&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjky,4:15 PM – 4:27 PM US PT,Preliminary Results from a Clinical Trial Comparing the Efficacy of Cefixime Versus Penicillin G for the Treatment of Early Syphilis,
328,1498403,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498403&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkz,3:15 PM – 3:30 PM US PT,Attenuated PreFusion F Antibody Response to RSV Vaccines in Solid Organ Transplant Recipients,
328,1498398,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498398&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkz,3:30 PM – 3:45 PM US PT,Robust and Consistent Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) Across Different Age Ranges and Frailty Status in Older Adults,
328,1498394,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498394&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkz,3:45 PM – 4:00 PM US PT,"A Phase 2 Double-Blind, Placebo-Controlled Study Showing Oral Tableted Norovirus Vaccine VXA-G1.1-NN is Immunogenic, Efficacious, and Reduces Viral Shedding Following Norovirus Challenge",
328,1498390,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498390&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkz,4:00 PM – 4:15 PM US PT,Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) when Co-administered with Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US and Puerto Rico,
328,1498385,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498385&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkz,4:15 PM – 4:30 PM US PT,Effectiveness of the Original BNT162b2 Messenger RNA Vaccine Against COVID-19 Omicron Infection in Children Aged 6 Months to 4 Years in Japan,
329,1498402,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498402&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NTQ1,3:15 PM – 3:30 PM US PT,PIDS FEATURED ORAL ABSTRACT: Assessment of Bacterial Pathogens in Young Children with Acute Otitis Media: A Prospective Cohort Study in the United States (US),
329,1408031,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408031&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NTQ1,3:30 PM – 3:45 PM US PT,Awards Presentation,N/A
329,1500697,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1500697&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NTQ1,3:45 PM – 4:30 PM US PT,Congenital Cytomegalovirus (CMV): Playing the Long Game,
332,1408054,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408054&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIwMDUz,3:15 PM – 3:33 PM US PT,Weight gain on ART: Switch ART,
332,1408053,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408053&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIwMDUz,3:33 PM – 3:51 PM US PT,Weight gain on ART: Add weight loss agent,
332,1408051,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408051&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIwMDUz,3:51 PM – 4:09 PM US PT,Should we invest in non-occupational post-exposure prophylaxis (nPEP) as a tool to end the HIV epidemic? Pro,
332,1408052,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408052&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIwMDUz,4:09 PM – 4:30 PM US PT,Should we invest in non-occupational post-exposure prophylaxis (nPEP) as a tool to end the HIV epidemic? Con,
334,1423438,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423438&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDY0MjQz,4:45 PM – 5:05 PM US PT,Awards Presentation,N/A
334,1498384,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498384&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDY0MjQz,5:05 PM – 5:20 PM US PT,"IDSA FEATURED ORAL ABSTRACT: MVA-BN Induces a Low Avidity, Non-Durable Humoral Response Against Mpox Virus",
334,1500698,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1500698&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDY0MjQz,5:20 PM – 5:45 PM US PT,Advances and Challenges in Fungal Diagnostics,
340,1487487,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1487487&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDQz,8:00 AM – 9:00 AM US PT,Bioelectricity Antimicrobial Susceptibility Testing (BeAST) by Cytecom Ltd,
340,1487490,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1487490&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDQz,8:00 AM – 9:00 AM US PT,The PhAST BC GN Assay: Rapid phenotypic AST for bloodstream infections,
340,1487489,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1487489&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDQz,8:00 AM – 9:00 AM US PT,Deepull: Ullcore BSI test - One hour direct-from-blood multiplex PCR targeting 95% of sepsis-causing pathogens and select resistant markers,
340,1487491,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1487491&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDQz,8:00 AM – 9:00 AM US PT,,
341,1407879,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407879&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEwMjMw,8:00 AM – 8:30 AM US PT,AAP Redbook: Highlights for 2024-2027 Part 1,
341,1407878,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407878&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEwMjMw,8:30 AM – 9:00 AM US PT,AAP Redbook: Highlights for 2024-2027 Part 2,
342,1407885,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407885&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzcw,8:00 AM – 8:30 AM US PT,Medical Tourist Beware! A Review of Recent Outbreaks Related to Medical Tourism,
342,1407884,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407884&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzcw,8:30 AM – 9:00 AM US PT,Anatomy of a Recall: Outbreaks Due to Product Contamination,
343,1407900,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407900&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTQ3,8:00 AM – 8:20 AM US PT,Case based discussion on optimizing billing and coding to impact reimbursement and quality metrics,
343,1407899,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407899&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTQ3,8:20 AM – 8:40 AM US PT,Coding For Our Value--ID Complex Care,
343,1407898,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407898&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTQ3,8:40 AM – 9:00 AM US PT,Practical methods to enhance ID physician reimbursement,
344,1407905,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407905&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzY4,8:00 AM – 8:30 AM US PT,Bronchiectasis and Non-Tuberculosis Mycobacteria,
344,1407904,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407904&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzY4,8:30 AM – 9:00 AM US PT,Current Treatment Approach for NTM lung Infection,
345,1407934,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407934&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyODE1,8:00 AM – 8:30 AM US PT,Beta-Lactam Adjunctive Therapy for Difficult Infections,
345,1407933,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407933&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyODE1,8:30 AM – 9:00 AM US PT,Beta-Lactam Adjunctive Therapy for Difficult Enterococcal Infections,
346,1408026,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408026&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyOTQ4,8:00 AM – 8:30 AM US PT,Utilizing Clinic-based Interventions to Re-engage the Struggling Patient,
346,1408027,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408027&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyOTQ4,8:30 AM – 9:00 AM US PT,Managing Depression and Anxiety in the HIV Clinic,
347,1408033,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408033&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTU3,8:00 AM – 8:30 AM US PT,Review of Progress and Challenges in Bacterial Meningitis and Encephalitis,
347,1408032,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408032&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTU3,8:30 AM – 9:00 AM US PT,Updates in viral encephalitis and emerging concepts,
348,1408041,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408041&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjcz,8:00 AM – 8:30 AM US PT,What We Know So Far,
348,1408040,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408040&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjcz,8:30 AM – 9:00 AM US PT,Implementation Successes and Challenges,
349,1408055,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408055&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTMz,8:00 AM – 8:30 AM US PT,Local Metrics to Push Stewardship Programs Forward,
349,1408056,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408056&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTMz,8:30 AM – 9:00 AM US PT,Not Just Antibiotic Use: Patient Outcomes Data to Support Stewardship,
350,1408127,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408127&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTc5,8:00 AM – 8:30 AM US PT,Transforming Your Work in Clinical Education: Pearls for Producing Scholarship,
350,1408128,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408128&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTc5,8:30 AM – 9:00 AM US PT,Teaching ID by Podcast,
355,1464242,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1464242&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDQy,9:15 AM – 9:35 AM US PT,Awards Presentation,N/A
355,1500696,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1500696&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDQy,9:35 AM – 10:00 AM US PT,"Beta-lactamase Inhibitors: Advancements, Challenges, and Opportunities",
359,1407876,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407876&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTc2,10:30 AM – 10:55 AM US PT,How Did We Get Here?: How Law Impacts Population Health & Clinical Disparities in ID,
359,1407874,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407874&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTc2,10:55 AM – 11:20 AM US PT,Achieving Health Equity by Creating Diversity in the era of a Colorblind Constitution,
359,1407875,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407875&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTc2,11:20 AM – 11:45 AM US PT,Using Psychological Safety to Create an Inclusive Learning Environment,
360,1407894,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407894&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEzOTA2,10:30 AM – 10:55 AM US PT,Three days of antibiotics for uncomplicated community-acquired pneumonia: Ready for prime time?,
360,1407892,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407892&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEzOTA2,10:55 AM – 11:20 AM US PT,Do we still need to treat group A Streptococcus pharyngitis for 10 days?,
360,1407893,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407893&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEzOTA2,11:20 AM – 11:45 AM US PT,Daptomycin and statins: To hold or not to hold,
361,1407908,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407908&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2Mzc1,10:30 AM – 10:55 AM US PT,Prediction Models 101: The Data,
361,1407907,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407907&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2Mzc1,10:55 AM – 11:20 AM US PT,Prediction Models 101: The Models,
361,1407906,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407906&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2Mzc1,11:20 AM – 11:45 AM US PT,Prediction Models 101: The Implementation and Automation,
362,1494613,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1494613&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDQx,10:30 AM – 10:50 AM US PT,Global Epidemiology of Mpox in 2024,
362,1494618,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1494618&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDQx,10:50 AM – 11:10 AM US PT,Palm007: Clinical Efficacy of Tecovirimat in Hospitalized Patients with Mpox,
362,1494617,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1494617&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDQx,11:10 AM – 11:30 AM US PT,Alternative Antiviral Therapies for Treating Severe Mpox Infection,
362,1494616,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1494616&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDQx,11:30 AM – 11:45 AM US PT,Challenging Issues in Mpox Vaccination,
363,1408002,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408002&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyNzMw,10:30 AM – 10:55 AM US PT,The impact of antimicrobial resistance in patients with hematological malignancies and hematopoietic stem cell transplant recipients,
363,1408004,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408004&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyNzMw,10:55 AM – 11:20 AM US PT,Is it time to re-design the empiric antibacterial approach in febrile neutropenia?,
363,1408003,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408003&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyNzMw,11:20 AM – 11:45 AM US PT,Quinolone prophylaxis: a double-edged sword?,
364,1408018,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408018&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIwMTE4,10:30 AM – 10:55 AM US PT,Viral AMR Detection,
364,1408017,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408017&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIwMTE4,10:55 AM – 11:20 AM US PT,Fungal AMR Detection,
364,1408016,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408016&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIwMTE4,11:20 AM – 11:45 AM US PT,Bacterial AMR Detection,
365,1408029,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408029&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3NTI1,10:30 AM – 10:55 AM US PT,The Big Picture: Our National Framework For Caring For Patients With Special Pathogens.,
365,1408028,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408028&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3NTI1,10:55 AM – 11:20 AM US PT,"Preparing your Hospital: From Identify, Isolate and Inform to Simulation and Training",
365,1408030,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408030&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3NTI1,11:20 AM – 11:45 AM US PT,The Bioethics of Caring for a patient with a Special Pathogen: family-centered care and beyond,
366,1408046,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408046&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDI1,10:30 AM – 10:55 AM US PT,What's the latest data and experience on LAI treatment and prevention?,
366,1408045,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408045&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDI1,10:55 AM – 11:20 AM US PT,PEPFAR:  Strategies to accelerate towards ending the epidemic and sustaining the gains,
366,1408044,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408044&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDI1,11:20 AM – 11:45 AM US PT,Treatment and prevention pipeline: What's coming?,
367,1498446,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498446&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAy,10:30 AM – 10:45 AM US PT,,
367,1498442,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498442&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAy,10:45 AM – 11:00 AM US PT,Predictors of Undetectable HDV RNA 48 weeks after completion of finite treatment with Bulevirtide and Pegylated-Interferon Alpha 2a,
367,1498438,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498438&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAy,11:00 AM – 11:15 AM US PT,Improving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin-Structure Infections,
367,1498434,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498434&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAy,11:15 AM – 11:30 AM US PT,Improved Survival with Dual Immunomodulator Treatment of ARDS by blocking C5a and IL-6 Activity: Subanalysis from the PANAMO Study in Critically Ill COVID-19 Patients,
367,1498429,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498429&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAy,11:30 AM – 11:45 AM US PT,,
368,1498447,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498447&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAx,10:30 AM – 10:42 AM US PT,,
368,1498443,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498443&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAx,10:42 AM – 10:54 AM US PT,Efficacy of nirmatrelvir-ritonavir in high-risk trial participants with prior SARS-CoV-2 infection or vaccination: a pooled analysis,
368,1498439,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498439&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAx,10:54 AM – 11:06 AM US PT,First-in-human study of a novel half-life extended monoclonal antibody (GB-0669) against SARS-CoV2 and related sarbecoviruses,
368,1498435,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498435&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAx,11:06 AM – 11:18 AM US PT,,
368,1498431,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498431&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAx,11:18 AM – 11:30 AM US PT,Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating Pemivibart,
368,1498430,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498430&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAx,11:30 AM – 11:43 AM US PT,Obeldesivir Reduced SARS-CoV-2 Infectious Titers in the BIRCH Phase 3 Clinical Trial,
369,1498445,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498445&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAz,10:30 AM – 10:45 AM US PT,Biomarkers of Amphotericin-Induced Complement Activation and Associated Clinical Manifestations,
369,1498441,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498441&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAz,10:45 AM – 11:00 AM US PT,,
369,1498437,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498437&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAz,11:00 AM – 11:15 AM US PT,Novel Antifungal Olorofim Use in Intractable CNS and Non-CNS Disseminated Coccidioidomycosis,
369,1498433,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498433&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAz,11:15 AM – 11:30 AM US PT,"bloodstream infections are comprised of diverse populations of strains, including antifungal tolerant strains that emerge during treatment failure",
369,1498428,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498428&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzAz,11:30 AM – 11:45 AM US PT,Hemophagocytic Lymphohistiocytosis in Disseminated Histoplasmosis: an Overlooked Diagnosis,
370,1498444,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498444&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzA0,10:30 AM – 10:45 AM US PT,,
370,1498440,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498440&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzA0,10:45 AM – 11:00 AM US PT,"Impact of Covid-19, Divergent Genomic Modes of Transmission and Strain Replacement of Carbapenem-Resistant Organisms in a Single Hospital in Singapore over 12 years",
370,1498436,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498436&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzA0,11:00 AM – 11:15 AM US PT,"Genomic epidemiology of carbapenemase-producing species in Toronto, Canada, 2007-2021",
370,1498432,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498432&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzA0,11:15 AM – 11:30 AM US PT,Patients with Carbapenem-resistant and complex Colonization or Infection Have Different Baseline Characteristics but Similar Mortality and Clinical Outcomes,
370,1498427,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498427&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzA0,11:30 AM – 11:45 AM US PT,,
375,1498289,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498289&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzc0,12:15 PM – 12:20 PM US PT,Evaluation of a multifaceted intervention on the management of uncomplicated gram-negative bacteremia,
375,1498237,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498237&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzc0,12:20 PM – 12:25 PM US PT,Effectiveness of Oral Step-down Antibiotic Therapy in Uncomplicated Bloodstream Infection,
375,1498233,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498233&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzc0,12:25 PM – 12:30 PM US PT,Injection-Related Skin Ulcers: a Common and Poorly Addressed Risk Factor for Rehospitalization among People who Inject Drugs in the CHOICE+ Cohort,
375,1498229,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498229&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzc0,12:30 PM – 12:35 PM US PT,Clinical Diagnostic Performance of Droplet Digital PCR for Pathogen Detection in Patients with Bloodstream Infections,
375,1498285,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498285&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzc0,12:35 PM – 12:40 PM US PT,"Results from A Phase 2 Clinical Trial for Treatment of Bone And Joint Infections with Afabicin, A First-in-Class Selective Anti-Staphylococcal Antibiotic",
376,1498238,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498238&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcx,12:15 PM – 12:20 PM US PT,Prevalence of Hepatitis B Co-infection in People with HIV by Birth Cohort– Potential Impact of HBV Vaccination Availability,
376,1498234,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498234&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcx,12:20 PM – 12:25 PM US PT,,
376,1498230,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498230&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcx,12:25 PM – 12:30 PM US PT,Breast Cancer (BC) and Colorectal Cancer (CRC) Screenings among Persons with HIV (PWH): The Role of Individual and System-Level Factors on Screening Completion,
376,1498286,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498286&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcx,12:30 PM – 12:35 PM US PT,Polymorphonuclear Myeloid-Derived Suppressor Cells  regulates immune reconstitution during HIV infection  through PD-L1 and TGF-? signaling,
376,1498282,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498282&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcx,12:35 PM – 12:40 PM US PT,Assessment of Failures of Long-Acting Cabotegravir and Rilpivirine in a Real-World Treatment Setting,
376,1498280,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498280&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcx,12:40 PM – 12:45 PM US PT,Implementation and Uptake of Long-acting Injectable PrEP at Atlanta VA Healthcare System,
377,1498240,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498240&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcy,12:15 PM – 12:20 PM US PT,Comparison of Adverse Drug Effects and Incidence of CMV Infection Between Different Dosing Regimens for Valganciclovir in the Pediatric Solid Organ Transplant Population,
377,1498236,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498236&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcy,12:20 PM – 12:25 PM US PT,"Prolonged Mpox Infections in California, May 2022 – March 2023",
377,1498232,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498232&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcy,12:25 PM – 12:30 PM US PT,,
377,1498288,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498288&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcy,12:30 PM – 12:35 PM US PT,Comparison of Diagnostic Performance between Induced Sputum or Tracheal Suction and Bronchoalveolar Lavage Fluid for Diagnosis of Pneumonia Using Quantitative PCR,
377,1498284,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498284&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcy,12:35 PM – 12:40 PM US PT,Efficacy of Wolbachia-mediated sterility to suppress dengue,
378,1498239,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498239&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcz,12:15 PM – 12:20 PM US PT,,
378,1498235,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498235&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcz,12:20 PM – 12:25 PM US PT,Burdens in Outdoor and Indoor Air at Hospitals Housing Patients at High Risk for Invasive Fungal Infections,
378,1498231,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498231&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcz,12:25 PM – 12:30 PM US PT,,
378,1498287,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498287&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcz,12:30 PM – 12:35 PM US PT,Culture-based Viability PCR: Strategies to Harness its Sensitivity and Minimize False Positives,
378,1498283,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498283&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcz,12:35 PM – 12:40 PM US PT,Accurate Ribotype Prediction from Whole Genome Sequencing Data Using Machine Learning,
378,1498281,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498281&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzcz,12:40 PM – 12:45 PM US PT,Evolution of difficile Antimicrobial Susceptibility within the epidemic REA Group BI (RT027) and the endemic REA group Y (RT014/020),
381,1407896,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407896&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2MTYx,1:45 PM – 2:10 PM US PT,Pneumocystis: New hosts and new treatments,
381,1407897,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407897&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2MTYx,2:10 PM – 2:35 PM US PT,"Coccidioidomycosis: new thoughts on ecology, epidemiology, diagnosis, and treatment",
381,1407895,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407895&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2MTYx,2:35 PM – 3:00 PM US PT,Mucormycosis,
382,1407953,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407953&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDIx,1:45 PM – 2:10 PM US PT,Cutting Edge ART in 2024,
382,1407955,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407955&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDIx,2:10 PM – 2:35 PM US PT,HIV Primary Care: Modern Challenges and Guideline Update,
382,1407954,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407954&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDIx,2:35 PM – 3:00 PM US PT,Opportunistic Infection Management: New Aspects to an Old Foe,
383,1489133,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1489133&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDMy,1:45 PM – 2:10 PM US PT,H5N1 Outbreak in Dairy Cattle: Transmission and Natural History Studies,
383,1489134,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1489134&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDMy,2:10 PM – 2:35 PM US PT,Ensuring the Safety of Milk Products During the H5N1 Outbreak in Dairy Cattle,
383,1489135,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1489135&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDMy,2:35 PM – 3:00 PM US PT,H5N1 risk in Farm Workers: The Colorado Experience,
384,1407972,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407972&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTkz,1:45 PM – 2:03 PM US PT,Clinical Approach to Fever of Unknown Origin,
384,1407974,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407974&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTkz,2:03 PM – 2:21 PM US PT,Fever of Unknown Origin: The current landscape,
384,1407973,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407973&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTkz,2:21 PM – 2:39 PM US PT,Diagnosing infections and monitoring treatment response,
384,1407971,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407971&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTkz,2:39 PM – 3:00 PM US PT,Novel Imaging Approaches for Infectious Diseases,
385,1407956,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407956&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTI1,1:45 PM – 2:10 PM US PT,Host biomarkers for infectious diseases diagnosis: What’s current and what’s coming,
385,1407958,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407958&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTI1,2:10 PM – 2:35 PM US PT,Host biomarker tests for distinction of bacterial versus viral infection: overview and clinical case study,
385,1407957,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407957&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTI1,2:35 PM – 3:00 PM US PT,Using host biomarkers to drive pathogen discovery,
386,1412300,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1412300&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3Mzkw,1:45 PM – 2:10 PM US PT,IDSA COVID-19 Treatment Guideline updates,
386,1419553,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1419553&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3Mzkw,2:10 PM – 2:35 PM US PT,New influenza countermeasures: What's coming?,
386,1409804,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1409804&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3Mzkw,2:35 PM – 3:00 PM US PT,RSV Prevention at 1 year,
387,1408069,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408069&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzcx,1:45 PM – 2:10 PM US PT,Re-thinking Regimens and Duration for Peri-Operative Prophylaxis,
387,1408071,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408071&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzcx,2:10 PM – 2:35 PM US PT,Where are we with management of pediatric spinal hardware infections?,
387,1408070,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408070&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzcx,2:35 PM – 3:00 PM US PT,When and How Often Do We Need to Debride: ENT Management of Invasive Fungal Sinusitis in Children,
388,1408130,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408130&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE4NTA2,1:45 PM – 2:10 PM US PT,Genomic Surveillance: The Future of Infection Prevention in Hospitals,
388,1408129,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408129&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE4NTA2,2:10 PM – 2:35 PM US PT,A case study in developing an in-house funded WGS surveillance program,
388,1408131,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408131&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE4NTA2,2:35 PM – 3:00 PM US PT,Peaking inside the black box: practical issues of WGS surveillance,
389,1498358,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498358&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg2,1:45 PM – 2:00 PM US PT,Amoxicillin Direct Oral Challenge in Patients with High-Risk Allergic Reaction,
389,1498354,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498354&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg2,2:00 PM – 2:15 PM US PT,Antibiotic Stewardship Program Improved the Susceptibility of Commonly Seen Gram-negative Bacilli Over 12 Years at Singapore General Hospital,
389,1498350,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498350&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg2,2:15 PM – 2:30 PM US PT,Enhancing antimicrobial stewardship capacity building and communication across multidisciplinary departments in Chinese hospitals: a national qualitative study,
389,1498346,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498346&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg2,2:30 PM – 2:45 PM US PT,,
389,1498340,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498340&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg2,2:45 PM – 3:00 PM US PT,Antibiotic Stewardship at a New York City Public Hospital NICU using Neonatal Early-Onset Sepsis Calculator in the Presence of Maternal Chorioamnionitis,
390,1498360,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498360&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg0,1:45 PM – 1:57 PM US PT,,
390,1498356,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498356&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg0,1:57 PM – 2:09 PM US PT,"Social Determinants of Vaccine Uptake: The Impact of Race and Vulnerability on Influenza, SARS-CoV-2, and RSV Vaccination Rates",
390,1498352,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498352&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg0,2:09 PM – 2:21 PM US PT,Impact of Updated 2020 Public Health Service Guidelines on Deceased Organ Donors and Transplant Recipients,
390,1498348,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498348&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg0,2:21 PM – 2:33 PM US PT,Closing Care Gaps: Optimizing Pre-Transplant Testing,
390,1498344,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498344&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg0,2:33 PM – 2:45 PM US PT,Early Discontinuation of Empiric Antibiotics for Febrile Neutropenia in Pediatric Allogeneic Haploidentical Hematopoietic Cell Transplant Recipients,
390,1498342,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498342&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg0,2:45 PM – 2:57 PM US PT,Back to School Unequal: Neighborhood Disadvantage and Asthma-related Emergency Department Visits in School-Aged Children,
392,1498359,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498359&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg3,1:45 PM – 1:57 PM US PT,A Hot Topic: the Relationship Between Climate Variability and Vector Specific Trends in Tick-Borne Diseases in New Jersey,
392,1498355,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498355&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg3,1:57 PM – 2:09 PM US PT,,
392,1498351,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498351&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg3,2:09 PM – 2:21 PM US PT,"National Trends and Racial Disparities in Sepsis-Related Mortality in Children in the United States, 1999-2019",
392,1498347,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498347&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg3,2:21 PM – 2:33 PM US PT,,
392,1498343,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498343&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg3,2:33 PM – 2:45 PM US PT,Pathogen-Harboring Ticks are Prevalent in Suburban Green Spaces in Central North Carolina,
392,1498341,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498341&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg3,2:45 PM – 2:57 PM US PT,"High Rates of Bacteremia and Fluoroquinolone Resistance during an Outbreak of Shigellosis among People Experiencing Homelessness and Opioid Use Disorder in Philadelphia, PA",
393,1498357,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498357&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg1,1:45 PM – 2:00 PM US PT,Co-Testing: Increasing HIV Testing in Patients Undergoing Sexually Transmitted Infection Evaluation in a Large Integrated Healthcare Network,
393,1498353,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498353&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg1,2:00 PM – 2:15 PM US PT,Trends in HIV-Related Mortality Among Reproductive-Aged Women in the United States,
393,1498349,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498349&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg1,2:15 PM – 2:30 PM US PT,,
393,1498345,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498345&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg1,2:30 PM – 2:45 PM US PT,Modified Human Immunodeficiency Virus Testing Algorithm in Rural Missouri (MOdified HIV testing algorithm),
393,1498339,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498339&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg1,2:45 PM – 3:00 PM US PT,"Antiretroviral Prophylaxis to Prevent Perinatal HIV Infection in Medicaid-Insured Infants, 2009-2021",
398,1424417,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424417&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzEy,3:15 PM – 3:40 PM US PT,We are Made from Stories:  Narrative Medicine and Finding your Inner Writer,
398,1424448,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424448&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzEy,3:40 PM – 4:05 PM US PT,"Narrative Medicine as a Method for Deep Engagement with Self, Other, and System",
398,1424513,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424513&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzEy,4:05 PM – 4:30 PM US PT,Using Poetry in Clinical Care and Education,
399,1407943,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407943&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjg4,3:15 PM – 3:40 PM US PT,A Drive into the LVAD infections: approach and management,
399,1407944,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407944&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjg4,3:40 PM – 4:05 PM US PT,Emo about ECMO: Addressing Infectious Challenges,
399,1407942,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407942&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjg4,4:05 PM – 4:30 PM US PT,Dosing Antimicrobials in Patients Requiring Mechanical Circulatory Support,
400,1405693,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1405693&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA1Njky,3:15 PM – 3:40 PM US PT,Cytokines and Systemic Inflammation During Neonatal Sepsis,
400,1405694,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1405694&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA1Njky,3:40 PM – 4:05 PM US PT,Klebsiella Pneumoniae Blood Stream Infection: Host Factors and Immunity,
400,1405691,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1405691&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA1Njky,4:05 PM – 4:30 PM US PT,Sepsis and the Microbiome,
401,1407982,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407982&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIyOTk0,3:15 PM – 3:40 PM US PT,Influential Publications in Healthcare Epidemiology from the Past Year,
401,1407983,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407983&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIyOTk0,3:40 PM – 4:05 PM US PT,Influential Publications in Antimicrobial Stewardship from the Past Year,
401,1407984,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407984&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIyOTk0,4:05 PM – 4:30 PM US PT,Influential Publications in Public Health from the Past Year,
402,1411104,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1411104&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDExMTAx,3:15 PM – 3:40 PM US PT,The Challenges in STI management in Latin America,
402,1411111,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1411111&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDExMTAx,3:40 PM – 4:05 PM US PT,PrEP and Treatment of HIV in LATAM,
402,1411112,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1411112&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDExMTAx,4:05 PM – 4:30 PM US PT,Emerging STIs in The Caribbean,
403,1408065,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408065&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTMy,3:15 PM – 3:40 PM US PT,Working with Surgical Teams to Support Stewardship,
403,1408063,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408063&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTMy,3:40 PM – 4:05 PM US PT,Targeting Tough Transplant Cases for Antimicrobial Stewardship,
403,1408064,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408064&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTMy,4:05 PM – 4:30 PM US PT,Evaluating the Evidence for Antimicrobial Stewardship in the OB/GYN Population,
404,1408112,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408112&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3Mzg5,3:15 PM – 3:40 PM US PT,COVID-19 in Children:  the Current Landscape in the midst of Vaccine Hesitancy,
404,1408111,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408111&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3Mzg5,3:40 PM – 4:05 PM US PT,Pediatric Enteroviruses: Infections from Head to Toe,
404,1408113,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408113&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3Mzg5,4:05 PM – 4:30 PM US PT,Adenovirus Infections within the United States: Surveillance and Outbreaks,
405,1498336,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498336&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgw,3:15 PM – 3:30 PM US PT,Culture Clash: A Comparison of Approach to Blood Culture Diagnostic Stewardship across 3 Emergency Departments in a Healthcare Network,
405,1498332,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498332&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgw,3:30 PM – 3:45 PM US PT,Optimizing Blood Culture Utilization in Solid Organ Transplant Recipients: A Diagnostic Stewardship Approach,
405,1498328,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498328&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgw,3:45 PM – 4:00 PM US PT,Impact of clinical diagnostic stewardship of respiratory cultures across a multicenter PICU collaborative,
405,1498324,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498324&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgw,4:00 PM – 4:15 PM US PT,Should We Be Doing This? Evaluating Pleural Fluid Inoculation into Blood Culture Bottles.,
405,1498318,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498318&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgw,4:15 PM – 4:30 PM US PT,Comparing the Effects of Commercial to Manual Initial Specimen Diversion Techniques (ISDT) on Clinical Outcomes and Institutional Costs,
406,1498335,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498335&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgy,3:15 PM – 3:30 PM US PT,"Changing Epidemiology of Pediatric Invasive Group A Infections in the United States, 2004-2022",
406,1498331,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498331&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgy,3:30 PM – 3:45 PM US PT,Immunization Impact on Serotype Distribution of Invasive Pneumococcal Disease - Playing the Serotype Whack-A-Mole!,
406,1498327,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498327&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgy,3:45 PM – 4:00 PM US PT,Acute Rheumatic Fever at a US Children's Hospital During a Period of Fluctuating Group A Incidence,
406,1498323,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498323&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgy,4:00 PM – 4:15 PM US PT,Household Economic Burden and Social Consequences of Childhood Severe Pneumonia in India: A Cost of Illness based Pharmacoeconomic Analysis,
406,1498317,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498317&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgy,4:15 PM – 4:30 PM US PT,Mirror Mirror on the Wall Who is Driving all the Invasive GAS After All - The Utah Experience,
407,1498338,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498338&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgx,3:15 PM – 3:27 PM US PT,"SARS-CoV-2 Positivity and Genetic Relationships among Cases within Households in the Cascadia Prospective Cohort Study, July 2022 to May 2023",
407,1498334,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498334&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgx,3:27 PM – 3:39 PM US PT,Revealing Seasonal Patterns in the Post-Pandemic Era: A Comparative Analysis of Burden and Seasonality of Influenza and COVID-19 in Europe and the US.,
407,1498330,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498330&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgx,3:39 PM – 3:51 PM US PT,"Effectiveness of Updated (2023-2024) Monovalent COVID-19 Vaccines – VISION Network, September 2023-March 2024",
407,1498326,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498326&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgx,3:51 PM – 4:03 PM US PT,"Underlying Medical Conditions and Vaccination Status among U.S. Children Aged ?17 Years Hospitalized for COVID-19 in COVID-19-Associated Hospitalization Surveillance Network (COVID-NET), January–December 2023",
407,1498322,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498322&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgx,4:03 PM – 4:15 PM US PT,"Severe Acute Respiratory Syndrome Coronavirus 2 Household Transmission during the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study using Genomic Epidemiology",
407,1498320,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498320&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjgx,4:15 PM – 4:27 PM US PT,SARS-CoV-2 Fecal Shedding Dynamics Among People with Symptomatic COVID-19,
408,1498337,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498337&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc5,3:15 PM – 3:27 PM US PT,Tumor microbiota and tumor-infiltrating T cells in the tumor microenvironment of colorectal cancer,
408,1498333,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498333&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc5,3:27 PM – 3:39 PM US PT,Engraftment of donor derived anaerobic taxa and durable long-term multidrug resistant organism decolonization following fecal microbiota transplantation,
408,1498329,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498329&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc5,3:39 PM – 3:51 PM US PT,High-fat diet changed Salmonella infection patten associated with increasing intestinal permeability and altering gut microbiota,
408,1498325,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498325&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc5,3:51 PM – 4:03 PM US PT,Impact of Antibiotics on the Gut Microbiota: Comparisons Using Model-Based Analyses,
408,1498321,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498321&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc5,4:03 PM – 4:15 PM US PT,Reduced Gut Microbiome Diversity and Compositional Characteristics are Associated with Postoperative Infection in Heart Transplant Recipients,
408,1498319,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498319&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc5,4:15 PM – 4:27 PM US PT,Evaluation of Fecal Pharmacokinetics and Metagenomic Changes Following the Administration of Intravenous Omadacycline to Healthy Subjects,
410,1416693,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1416693&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTM5,3:15 PM – 3:33 PM US PT,Fidaxomicin isn't necessary with Vancomycin and Bezlotuxumab: Pro,
410,1412779,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1412779&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTM5,3:33 PM – 3:51 PM US PT,Fidaxomicin isn't necessary with Vancomycin and Bezlotuxumab: Con,
410,1404695,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1404695&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTM5,3:51 PM – 4:09 PM US PT,Hospital Onset Bacteremia should be used as a pay for performance measure: Pro,
410,1412134,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1412134&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTM5,4:09 PM – 4:30 PM US PT,Hospital Onset Bacteremia should be used as a pay for performance measure: Con,
411,1408050,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408050&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MDcz,3:15 PM – 3:33 PM US PT,Should We Prioritize Switching Suppressed PWH to Two Drugs? - Pro,
411,1408049,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408049&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MDcz,3:33 PM – 3:51 PM US PT,Should We Prioritize Switching Suppressed PWH to Two Drugs? - Con,
411,1408048,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408048&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MDcz,3:51 PM – 4:09 PM US PT,Should We Ramp Up PrEP Initiation in Pharmacies? - Pro,
411,1408047,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408047&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA0MDcz,4:09 PM – 4:30 PM US PT,Should We Ramp Up PrEP Initiation in Pharmacies? - Con,
413,1423191,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423191&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMTg2,4:45 PM – 5:10 PM US PT,Welcome & Awards Presentation,N/A
413,1498316,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498316&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMTg2,5:10 PM – 5:30 PM US PT,SHEA FEATURED ORAL ABSTRACT: : A 92-Hospital Cluster Randomized Trial of telligent tewardship rompts to mprove eal-time mpiric Antibiotic Selection versus Routine Antibiotic Selection Practices for Patients with Abdominal Infections,
413,1500709,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1500709&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMTg2,5:30 PM – 6:00 PM US PT,Musings on Growing the Next Generation of Healthcare Epidemiologists,
414,1500710,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1500710&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NTQ0,4:45 PM – 4:50 PM US PT,Introduction,
414,1496907,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1496907&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NTQ0,4:50 PM – 5:45 PM US PT,RSV Vaccine Development: From Tragedy to a New Era of Vaccinology,
414,1506436,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1506436&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NTQ0,5:45 PM – 5:50 PM US PT,Awards Presentation,N/A
414,1412268,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1412268&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NTQ0,5:50 PM – 6:00 PM US PT,Q&A,N/A
419,1463019,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1463019&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDYzMDE3,7:45 AM – 8:00 AM US PT,IDSA & HIVMA Policy Overview,
419,1463020,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1463020&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDYzMDE3,8:00 AM – 8:25 AM US PT,Advocacy in Action,
419,1463023,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1463023&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDYzMDE3,8:25 AM – 8:40 AM US PT,Congressional Engagement,
419,1463024,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1463024&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDYzMDE3,8:40 AM – 8:45 AM US PT,Member Advocacy Program,
419,1463267,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1463267&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDYzMDE3,8:45 AM – 9:00 AM US PT,Q&A,N/A
421,1487483,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1487483&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDM1,8:00 AM – 9:00 AM US PT,Zoliflodacin: Addressing a growing global threat through a novel public-private development partnership,
421,1487486,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1487486&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDM1,8:00 AM – 9:00 AM US PT,"Clarametyx Biosciences, CMTX-101",
421,1487484,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1487484&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDM1,8:00 AM – 9:00 AM US PT,AIC468 - a first-in-class antiviral antisense oligonucleotide for the treatment of BKV infection in kidney transplant recipients,
421,1487488,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1487488&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDM1,8:00 AM – 9:00 AM US PT,"Fosmanogepix, Basilea Pharmaceutica International Ltd, Allschwil (Switzerland)",
422,1407925,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407925&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTI2,8:00 AM – 8:30 AM US PT,Implementing DOOR in Registrational Antibacterial Trials,
422,1412181,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1412181&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTI2,8:30 AM – 9:00 AM US PT,DIY: how to perform DOOR analysis with your own dataset,
423,1407951,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407951&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5ODE5,8:00 AM – 8:30 AM US PT,The impact of synthetic opioids on HIV viral transmission and kinetics: Lessons from the bench,
423,1407952,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407952&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5ODE5,8:30 AM – 9:00 AM US PT,Chronic Pain in People with HIV: State of the Science,
424,1407963,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407963&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzEw,8:00 AM – 8:30 AM US PT,Spreading the Joy and Keeping it Fun: Teaching in the Context of a Busy Clinical Practice,
424,1407964,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407964&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzEw,8:30 AM – 9:00 AM US PT,Effective Incorporation of Health Equity Education Into ID Teaching,
425,1455418,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1455418&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDM2,8:00 AM – 8:30 AM US PT,ID Telehealth Model #1: The Access TeleCare Experience,
425,1455419,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1455419&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDM2,8:30 AM – 9:00 AM US PT,ID Telehealth Model #2: The Intermountain Health Experience,
426,1407976,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407976&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyNzcz,8:00 AM – 8:30 AM US PT,Duration of treatment of Gram-negative bacteremia in immunocompromised patients,
426,1407975,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407975&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyNzcz,8:30 AM – 9:00 AM US PT,Duration of treatment of infections caused by Pseudomonas aeruginosa and other non-fermenters in transplant or neutropenic patients: an appraisal of current evidence,
427,1408023,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408023&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2MzU4,8:00 AM – 8:30 AM US PT,Leveraging the WHO FFX-Dx protocol to drive rapid diagnostic development and deployment,
427,1408022,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408022&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2MzU4,8:30 AM – 9:00 AM US PT,Developing a Robust National Laboratory Response System Architecture,
428,1408025,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408025&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NTQz,8:00 AM – 8:30 AM US PT,Challengers: Papers from the past year that may challenge or change your Pediatric ID practice,
428,1408024,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408024&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NTQz,8:30 AM – 9:00 AM US PT,Challengers: Papers from the past year that may challenge or change your Pediatric ID practice,
429,1412293,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1412293&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzY3,8:00 AM – 8:30 AM US PT,Diagnosis of Periprosthetic Joint Infection,
429,1423257,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423257&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzY3,8:30 AM – 9:00 AM US PT,Prosthetic Joint Infections,
430,1408088,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408088&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTc4,8:00 AM – 8:30 AM US PT,Training the next generation: New Infection Prevention curriculum from SHEA,
430,1408087,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408087&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTc4,8:30 AM – 9:00 AM US PT,Nurturing the Next Generation of Stewards: A Look Into the SIDP Antimicrobial Stewardship Curriculum,
431,1408095,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408095&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTU0,8:00 AM – 8:30 AM US PT,Benefits and Risks of Multidrug Standard Therapy for Leprosy versus Alternative versus Second-Line Drug Regimens,
431,1408094,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408094&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTU0,8:30 AM – 9:00 AM US PT,Updates in the Management of Leprosy Reactions,
440,1464244,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1464244&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDM0,9:15 AM – 9:35 AM US PT,Awards Presentation,N/A
440,1500707,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1500707&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDM0,9:35 AM – 10:00 AM US PT,Human Infections with Highly Pathogenic Avian Influenza A(H5N1) Viruses and Pandemic Influenza Threats,
445,1407870,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407870&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIyNzEw,10:30 AM – 10:55 AM US PT,RSV prevention in infants: Use and impact of maternal vaccines and infant monoclonal antibodies,
445,1407869,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407869&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIyNzEw,10:55 AM – 11:20 AM US PT,RSV in adults: Epidemiology of severe RSV disease and RSV vaccines in the first year,
445,1407868,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407868&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIyNzEw,11:20 AM – 11:45 AM US PT,This just in: Pediatric and adult RSV immunization policy updates for the 2024-25 respiratory virus season,
446,1407890,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407890&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTUz,10:30 AM – 10:55 AM US PT,Advancing Antimicrobial Stewardship: Strategies for Optimizing Containment of Antimicrobial Resistance in Latin America and the Caribbean,
446,1407891,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407891&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTUz,10:55 AM – 11:20 AM US PT,Determinants of misuse of antibiotics in hospitals,
446,1407889,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407889&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTUz,11:20 AM – 11:45 AM US PT,Role of pharmacists in antimicrobial stewardship programs in LATAM,
447,1407920,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407920&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTY1,10:30 AM – 10:55 AM US PT,A One Health understanding of shifting zoonoses in the Arctic,
447,1402315,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1402315&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTY1,10:55 AM – 11:20 AM US PT,Adaptions of microbial populations in the Arctic,
447,1407919,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407919&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTY1,11:20 AM – 11:45 AM US PT,Building resiliency to address climate sensitive infectious disease,
448,1423260,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423260&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDIz,10:30 AM – 10:45 AM US PT,"Physician Compensation Updates, Trends & Tips",
448,1423258,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423258&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDIz,10:45 AM – 11:00 AM US PT,Quality/Outcome Based Incentives: The Road to Value,
448,1420114,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1420114&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDIz,11:00 AM – 11:15 AM US PT,Gender Equity in Compensation,
448,1402362,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1402362&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDIz,11:15 AM – 11:30 AM US PT,Compensation in Adult & Pediatric Academic Settings: Insisting on a Fair Allowance,
448,1402463,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1402463&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDIz,11:30 AM – 11:45 AM US PT,Panel Discussion,
449,1498781,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498781&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDMz,10:30 AM – 10:55 AM US PT,Dengue: from local risks to global epidemics,
449,1498935,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498935&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDMz,10:55 AM – 11:20 AM US PT,Presentation TBD 2,
449,1498936,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498936&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDMz,11:20 AM – 11:45 AM US PT,Topic 2: Advances in Dengue Prevention: New Insights and Challenges for Vaccination and Vector Control,
450,1407996,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407996&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIwMjU5,10:30 AM – 10:55 AM US PT,The Skin's Color and Clues Not to Miss,
450,1407997,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407997&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIwMjU5,10:55 AM – 11:20 AM US PT,Skin Manifestations in Immunocompromised Children,
450,1407998,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407998&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIwMjU5,11:20 AM – 11:45 AM US PT,Rheumatologic Mimickers of infectious Rashes,
451,1462443,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1462443&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDMw,10:30 AM – 10:50 AM US PT,An Assessment of Multi Drug Resistant Organism (MDRO) Reporting Processes in Tennessee,
451,1462444,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1462444&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDMw,10:50 AM – 11:10 AM US PT,Antibiotic Allergies in Long-Term Care Settings in Massachusetts: Current State and Paths Forward,
451,1462448,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1462448&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDMw,11:10 AM – 11:30 AM US PT,A Look at a LEAP Year,
451,1462449,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1462449&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDMw,11:30 AM – 11:45 AM US PT,Quantifying the Environmental Impact of MRSA/VRE Contact Precautions in Los Angeles County,
452,1408091,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408091&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEzOTA1,10:30 AM – 10:55 AM US PT,Aminopenicillins: Are they still a treatment option for ampicillin-resistant Enterococcus urinary tract infections?,
452,1408093,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408093&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEzOTA1,10:55 AM – 11:20 AM US PT,How should I select antibiotic agents for the treatment of diabetic foot infections?,
452,1408092,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408092&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEzOTA1,11:20 AM – 11:45 AM US PT,"Should I avoid piperacillin, tazobactam and vancomycin for patients at risk for acute kidney injury?",
453,1408125,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408125&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2MzYw,10:30 AM – 10:55 AM US PT,Emerging Fungal Infections,
453,1408124,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408124&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2MzYw,10:55 AM – 11:20 AM US PT,Precision Medicine in the Treatment of Fungal Infections,
453,1408126,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408126&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2MzYw,11:20 AM – 11:45 AM US PT,Comorbidities and Fungal Disease Beyond Immunosuppression: A Global View,
454,1498380,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498380&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkw,10:30 AM – 10:45 AM US PT,Association of a Hospital Stress Indicator with Device Associated Infections,
454,1498376,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498376&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkw,10:45 AM – 11:00 AM US PT,Assessment of Disinfectants for Reducing Burden on Needleless Connectors: an In Vitro Study,
454,1498372,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498372&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkw,11:00 AM – 11:15 AM US PT,Methods for Cost-efficient Real-time Whole Genome Sequencing Surveillance for Enhanced Detection of Outbreaks in a Hospital Setting,
454,1498368,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498368&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkw,11:15 AM – 11:30 AM US PT,MDR Risk Index: Multidrug-Resistant Bacteria Probability Score for General Hospitals,
454,1498361,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498361&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkw,11:30 AM – 11:45 AM US PT,Comparative In Vitro Microbiologic Activity of Two Antimicrobial Intravenous Connectors,
455,1498383,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498383&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg4,10:30 AM – 10:42 AM US PT,Host Response Profiling from Clinical Metagenomic Sequencing Data for Diagnosis of Central Nervous System Infections,
455,1498379,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498379&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg4,10:42 AM – 10:54 AM US PT,Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid for Central Nervous System Infections: Clinical Factors Associated with Increased Diagnostic Yield,
455,1498375,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498375&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg4,10:54 AM – 11:06 AM US PT,Clinical Experience with 16S Ribosomal RNA Gene PCR and Sequencing of Normally Sterile Body Fluids and Tissues in Pediatric Patients,
455,1498371,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498371&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg4,11:06 AM – 11:18 AM US PT,Clinical impact of a PCR assay on pleural fluid specimens for children with complicated pneumonia,
455,1498367,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498367&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg4,11:18 AM – 11:30 AM US PT,A Randomized Controlled Trial of Rapid Pathogen and Resistance Identification from Positive Blood Cultures,
455,1498364,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498364&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg4,11:30 AM – 11:43 AM US PT,The A-Stop Study: Rapid Tests for Infection in Non-neutropenic Critically-ill Patients - A Multicentre Diagnostic Test Accuracy Study,
456,1498382,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498382&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkx,10:30 AM – 10:42 AM US PT,Global Incidence of Viral Lower Respiratory Tract Disease (LRTD) Episodes and Hospitalizations (2010–2021),
456,1498378,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498378&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkx,10:42 AM – 10:54 AM US PT,Hospitalized Patients with Community-Acquired Pneumonia and Structural Lung Disease: A Multicenter Analysis,
456,1498374,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498374&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkx,10:54 AM – 11:06 AM US PT,Patient-Derived Airway Organoids: a Pre-clinical Platform to Model RSV Infection,
456,1498370,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498370&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkx,11:06 AM – 11:18 AM US PT,"Respiratory Syncytial Virus (RSV) Infections Among Persons Aged 60 Years and Older, by Vaccination Status, reported via Electronic Laboratory Reporting (ELR) – Los Angeles County (LAC), California",
456,1498366,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498366&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkx,11:18 AM – 11:30 AM US PT,Development and Validation of a LASSO-based Score to Predict 1-year Mortality After Discharge in Patients with Severe Pneumonia Admitted to the Intensive Care Unit,
456,1498363,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498363&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjkx,11:30 AM – 11:43 AM US PT,Detection of hemagglutinin H5 influenza A virus sequence in municipal wastewater solids during an outbreak of avian influenza,
457,1498381,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498381&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg5,10:30 AM – 10:42 AM US PT,,
457,1498377,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498377&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg5,10:42 AM – 10:54 AM US PT,Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) infections in the United States (CACTUS),
457,1498373,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498373&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg5,10:54 AM – 11:06 AM US PT,Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) infections in the United States (CACTUS),
457,1498369,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498369&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg5,11:06 AM – 11:18 AM US PT,Genomic Features Associated with Non-susceptibility to Cefiderocol in Pseudomonas aeruginosa and Cross-resistance to Novel ?-lactam/?-lactamase Inhibitors in the Prospective Observational Pseudomonas (POP) study,
457,1498365,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498365&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg5,11:18 AM – 11:30 AM US PT,Ceftazidime-Avibactam Versus Meropenem-Vaborbactam for the Treatment of Carbapenem-Resistant Enterobacterales Infections,
457,1498362,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498362&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjg5,11:30 AM – 11:43 AM US PT,Modeling Strain-Dependent Variability in Carbapenem-Resistant Colonization in the Malnourished Host,
462,1498279,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498279&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ2,12:15 PM – 12:20 PM US PT,"Activity of Gepotidacin against , Including Molecularly Characterized ESBL and Carbapenemase positive Subsets Causing Urinary Tract Infections in the United States (2019-2022)",
462,1498276,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498276&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ2,12:20 PM – 12:25 PM US PT,Real-World Effectiveness of Dalbavancin for Invasive Gram-Positive Bacterial Infections,
462,1498272,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498272&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ2,12:25 PM – 12:30 PM US PT,"Activity of Omadacycline Against 35,000 Bacterial Clinical Isolates and Resistant Organism Subsets from Patients in the United States (2019–2023)",
462,1498268,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498268&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ2,12:30 PM – 12:35 PM US PT,"Single-Dose and Repeat Single-Dose Ascending Dose Study Evaluating Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intramuscular CD388, a Novel Long-acting Drug-Fc Conjugate for Universal Prevention of Seasonal and Pandemic Influenza",
462,1498264,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498264&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ2,12:35 PM – 12:40 PM US PT,Assessment of Body Weight upon PK of Olorofim in Patients with Invasive Mould Infections,
462,1498261,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498261&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ2,12:40 PM – 12:45 PM US PT,"Characteristics and Real-world Outcomes of Patients Administered with Fecal Microbiota, live-jslm for the Prevention of Recurrent Infection (rCDI)",
463,1498277,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498277&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ1,12:15 PM – 12:20 PM US PT,Association Between Intimate Partner Violence and Antiretroviral Adherence Among Pregnant Women Living with HIV,
463,1498274,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498274&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ1,12:20 PM – 12:25 PM US PT,The Implementation Science Coordination Initiative (ISCI) for evidence-based HIV services: supporting implementation in practice,
463,1498270,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498270&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ1,12:25 PM – 12:30 PM US PT,Demographic and Clinical Characteristics of New Migrant Patients with HIV in a New York City Open Access HIV Primary Care Clinic,
463,1498266,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498266&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ1,12:30 PM – 12:35 PM US PT,Infective Endocarditis Outcomes in Older Patients with HIV,
463,1498263,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498263&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ1,12:35 PM – 12:40 PM US PT,"Decreasing Depressive Symptoms among Adults Living with HIV - United States Medical Monitoring Project (MMP), 2015-2022",
463,1498259,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498259&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ1,12:40 PM – 12:45 PM US PT,Are you PRePared After Transplant?,
464,1498278,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498278&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ0,12:15 PM – 12:20 PM US PT,Impact of Surveillance and Decolonization on MRSA and MSSA Infections in a Neonatal Intensive Care Unit,
464,1498275,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498275&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ0,12:20 PM – 12:25 PM US PT,"Dengue Epidemic Outbreak 2023-2024: is it here for good? Experience in a Tertiary Care Pediatric Hospital in Buenos Aires, Argentina",
464,1498271,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498271&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ0,12:25 PM – 12:30 PM US PT,Stratified Approach for Empiric Acyclovir in Neonates Presenting for Sepsis Evaluations,
464,1498267,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498267&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ0,12:30 PM – 12:35 PM US PT,Direct Impact of Pediatric Immunization on Reduction in Antibiotic Prescribing in the United States,
464,1498260,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498260&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQ0,12:40 PM – 12:45 PM US PT,Exploring Cost Savings through Reduced Sedation for Magnetic Resonance Imaging in Pediatric Osteomyelitis Diagnosis,
465,1498273,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498273&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQz,12:20 PM – 12:25 PM US PT,Carbapenemase Resistance Detection by Direct Xpert Carba-R Assay on Flagged Blood Cultures,
465,1498269,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498269&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQz,12:25 PM – 12:30 PM US PT,"Potential Impact of Targeted Sequencing on Central Line-associated Bloodstream Infection (CLABSI) at Stanford Health Care, 2015–2024",
465,1498265,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498265&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQz,12:30 PM – 12:35 PM US PT,,
465,1498262,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498262&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQz,12:35 PM – 12:40 PM US PT,Asymptomatic Bacteriuria Not a Predictor of Clinical Failure in Uncomplicated Urinary Tract Infections (uUTI): A Prospective Analysis of Women Treated for uUTI from the REASSURE Trial,
465,1498258,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498258&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzQz,12:40 PM – 12:45 PM US PT,Dabbling with Dalbavancin: Implementation and Cost-savings of an Inpatient-to-Outpatient Dalbavancin Pathway,
469,1407865,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407865&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzA1,1:45 PM – 2:03 PM US PT,The Antibiotic Prescribing Landscape for Pediatrics in the US,
469,1407863,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407863&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzA1,2:03 PM – 2:21 PM US PT,Sharing European Challenges and Successes in Pediatric Antimicrobial Stewardship,
469,1457891,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1457891&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzA1,2:21 PM – 2:39 PM US PT,Sharing European Challenges and Successes in Pediatric Antimicrobial Stewardship: UK,
469,1407867,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407867&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzA1,2:39 PM – 3:00 PM US PT,The Antibiotic Prescribing Landscape for Children Globally,
470,1407909,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407909&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTEy,1:45 PM – 2:10 PM US PT,IWGDF/IDSA Guidelines on the diagnosis and treatment of diabetes-related foot infections,
470,1407911,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407911&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTEy,2:10 PM – 2:35 PM US PT,Acute Bacterial Arthritis in Kids: The first IDSA/PIDS Guidelines have finally arrived,
470,1407910,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407910&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA3OTEy,2:35 PM – 3:00 PM US PT,IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections,
471,1407929,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407929&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzg4,1:45 PM – 2:10 PM US PT,Clinical Trials in Bacterial Diseases that may Change your Practice,
471,1407927,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407927&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzg4,2:10 PM – 2:35 PM US PT,Clinical Trials in Viral Diseases that may Change your Practice,
471,1407928,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407928&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzg4,2:35 PM – 3:00 PM US PT,Clinical Trials in Fungal Diseases that may Change your Practice,
472,1407935,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407935&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzc3,1:45 PM – 2:10 PM US PT,The Public Health Threat of Highly Pathogenic Avian Influenza A(H5N1) Viruses,
472,1407936,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407936&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzc3,2:10 PM – 2:35 PM US PT,Other Emerging Influenza Viruses with Species Crossover Potential,
472,1407937,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407937&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5Nzc3,2:35 PM – 3:00 PM US PT,What Happened to Influenza B/Yamagata and How Does This Impact Vaccine Composition?,
473,1407950,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407950&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzM3,1:45 PM – 2:10 PM US PT,The EMR and the ID physician,
473,1407948,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407948&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzM3,2:10 PM – 2:35 PM US PT,Finding the balance between Informatics & Infectious Diseases,
473,1407949,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407949&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzM3,2:35 PM – 3:00 PM US PT,"The ""Epic"" Challenge of Optimizing Antimicrobial Stewardship",
474,1412192,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1412192&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE1OTA3,1:45 PM – 2:10 PM US PT,Update on IE diagnosis,
474,1420084,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1420084&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE1OTA3,2:10 PM – 2:35 PM US PT,Percutaneous Mechanical Aspiration or Surgical Resection,
474,1423263,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423263&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE1OTA3,2:35 PM – 3:00 PM US PT,IVDU-associated IE antibiotic treatment,
475,1407985,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407985&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3Mzg4,1:45 PM – 2:10 PM US PT,Progress and Opportunities: CMV Prevention,
475,1407987,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407987&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3Mzg4,2:10 PM – 2:35 PM US PT,Treating refractory CMV in difficult cases,
475,1407986,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407986&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3Mzg4,2:35 PM – 3:00 PM US PT,Congenital CMV: A rapidly changing field,
476,1408000,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408000&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIyOTky,1:45 PM – 2:10 PM US PT,Emergency and outpatient implementation of Dalbavancin use,
476,1408001,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408001&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIyOTky,2:10 PM – 2:35 PM US PT,Inpatient use of Oritavancin for difficult-to-treat infections,
476,1407999,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407999&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIyOTky,2:35 PM – 3:00 PM US PT,Dalbavancin as an option for treatment of S. aureus bacteremia,
477,1405698,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1405698&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA1Njk3,1:45 PM – 2:10 PM US PT,Characterizing NTM Outbreaks Using Epidemiology and Genomics,
477,1405699,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1405699&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA1Njk3,2:10 PM – 2:35 PM US PT,Managing and Preventing NTM Outbreaks: Hospital Strategies,
477,1405696,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1405696&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA1Njk3,2:35 PM – 3:00 PM US PT,Post-Outbreak Management: Monitoring Clinical Response and Patient Outcomes,
478,1498291,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498291&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc0,1:45 PM – 2:03 PM US PT,Safety and Immunogenicity of Coadministered Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine With and Without Quadrivalent Influenza Vaccine in Adults ? 65 Years of Age,
478,1498487,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498487&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc0,2:03 PM – 2:21 PM US PT,"The Burden of RSV Infections Among Nursing Home Residents, Monroe County, NY, October 2022 to April 2023",
478,1498482,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498482&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc0,2:21 PM – 2:39 PM US PT,"CD388, a Novel Drug-Fc Conjugate (DFC), Demonstrates Prophylactic Activity in an Influenza Human Challenge Model",
478,1498478,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498478&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc0,2:39 PM – 2:59 PM US PT,Early Post-Marketing Safety Surveillance for the Respiratory Syncytial Virus Prefusion F Protein Vaccine (RSVPreF3 OA),
480,1498294,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498294&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcx,1:45 PM – 1:57 PM US PT,"Enhancing Diversity, Equity, Inclusion, Access, and Justice (DEIAJ) Teaching in Infectious Diseases: Current State and Future Directions in Faculty Development",
480,1498290,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498290&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcx,1:57 PM – 2:09 PM US PT,Feeling the Vibes: An Investigation Into Resident Physician Antibiotic Prescribing Practices,
480,1498486,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498486&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcx,2:09 PM – 2:21 PM US PT,"Increasing Diversity, Equity, and Inclusion in the Antimicrobial Stewardship Workforce through the SIDP Certificate Program",
480,1498483,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498483&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcx,2:21 PM – 2:33 PM US PT,Implementation and Evaluation of an Interactive Infectious Diseases Online Curriculum for Trainees on ID electives,
480,1498479,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498479&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcx,2:33 PM – 2:45 PM US PT,,
480,1498477,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498477&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcx,2:45 PM – 2:57 PM US PT,Let's Have a Chat: How Well Does an Artificial Intelligence Chatbot Answer Clinical Infectious Diseases Questions?,
481,1498293,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498293&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcy,1:45 PM – 2:00 PM US PT,Impact of the infectious site infection with Staphylococcus aureus in Europe: results from the economics of the SALT study,
481,1498489,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498489&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcy,2:00 PM – 2:15 PM US PT,The Association Between Contact Precautions for Methicillin-resistant (MRSA) Colonization and MRSA Bloodstream Infection (BSI) Rates in Los Angeles County Hospitals: Results of a Countywide Survey,
481,1498485,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498485&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcy,2:15 PM – 2:30 PM US PT,"Late Onset Invasive Group B Streptococcal Disease Outbreak in a Neonatal Intensive Care Unit Identified Through Whole Genome Sequencing — Connecticut, 2020–2024",
481,1498481,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498481&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcy,2:30 PM – 2:45 PM US PT,Impact of Universal Nasal Decolonization with an Alcohol-Based Nasal Antiseptic (ABNA) Versus Mupirocin on Infection Rates and Antimicrobial Utilization in Patients (Pts) Admitted to the Burn Service,
481,1498476,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498476&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcy,2:45 PM – 3:00 PM US PT,The Agency for Healthcare Research and Quality (AHRQ) Safety Program for MRSA Prevention: Impact of an Educational and Implementation Project in United States (US) Hospitals,
482,1498292,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498292&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcz,1:45 PM – 2:00 PM US PT,Immunogenicity and Safety of High-dose versus Double-dose Quadrivalent Inactivated Influenza Vaccine in Adult Kidney Transplant Recipients: A Randomized Controlled Trial,
482,1498488,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498488&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcz,2:00 PM – 2:15 PM US PT,"Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine",
482,1498484,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498484&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcz,2:15 PM – 2:30 PM US PT,"A Phase I, Multicenter, Randomized, Double-blind, Placebo-controlled Single Dose, Dose-ranging Study to Evaluate the Safety, Tolerability, and Immunogenicity of Orally Administered Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females ? 18 years Old and Their Breast-feeding Infants",
482,1498480,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498480&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcz,2:30 PM – 2:45 PM US PT,The Effect of Herpes Zoster Vaccination on New Diagnoses of Dementia: A Quasi-randomized Study in Australia,
482,1498475,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498475&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjcz,2:45 PM – 3:00 PM US PT,"Immunogenicity and Safety of BPZE1, an Intranasal Live Attenuated Pertussis Vaccine, Evaluated With and Without Tdap in Healthy Children 6 to 17 Years Old: A Phase 2b, Randomized, Active-Controlled Study",
485,1407888,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407888&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2Mzcz,3:15 PM – 3:40 PM US PT,Emerging Diagnostic Testing and Risk Stratification for Pediatric Community-Acquired Pneumonia,
485,1407886,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407886&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2Mzcz,3:40 PM – 4:05 PM US PT,What’s New with Management and Treatment of Pediatric Community-Acquired Pneumonia,
485,1407887,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407887&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2Mzcz,4:05 PM – 4:30 PM US PT,Challenges and Progress towards Diagnosis and Treatment of Infections with Mycoplasma pneumoniae,
486,1419196,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1419196&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzg1,3:15 PM – 3:40 PM US PT,Using large data and machine learning to identify intervention “hot spots” with a focus on improving antibiotic utilization,
486,1415748,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1415748&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzg1,3:40 PM – 4:05 PM US PT,Leveraging Big Data from the EHR to Control Transmission of Drug-Resistant Pathogens,
486,1420115,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1420115&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzg1,4:05 PM – 4:30 PM US PT,Non-traditional surveillance approaches for monitoring antimicrobial resistance and pathogens of global concern,
487,1407947,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407947&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTY5,3:15 PM – 3:40 PM US PT,Group A Streptococcus: Molecular Pathogenesis of Invasive Infection and Efforts Toward a Preventative Vaccine,
487,1407946,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407946&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTY5,3:40 PM – 4:05 PM US PT,Group A Streptococci; Clinical Stories from the Frontline,
487,1407945,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407945&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTY5,4:05 PM – 4:30 PM US PT,"What Happens Outside, Affects Inside: Controlling clusters of GAS in vulnerable healthcare settings",
488,1423262,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423262&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE1ODM5,3:15 PM – 3:40 PM US PT,Challenges and Opportunities for Bacteriophage Therapy,
488,1413903,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1413903&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE1ODM5,3:40 PM – 4:05 PM US PT,Therapeutic Phage Monitoring: Application in Children,
488,1423261,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423261&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE1ODM5,4:05 PM – 4:30 PM US PT,Clinical Phage Therapy Today: Stories from the Bedside and Insights from the Lab,
489,1408035,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408035&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjY1,3:15 PM – 3:40 PM US PT,Management of Substance Use Disorders in HIV clinic,
489,1408036,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408036&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjY1,3:40 PM – 4:05 PM US PT,Stimulants and HIV,
489,1408034,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408034&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMjY1,4:05 PM – 4:30 PM US PT,STIs and Sexual Health,
490,1408076,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408076&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIyNzA5,3:15 PM – 3:40 PM US PT,"Development of a multivalent extraintestinal pathogenic E. coli (ExPEC) vaccine: rationale, target groups, and progress in clinical trials",
490,1408075,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408075&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIyNzA5,3:40 PM – 4:05 PM US PT,A new vaccine for an ancient plague: development of a schistosomiasis vaccine,
490,1404027,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1404027&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIyNzA5,4:05 PM – 4:30 PM US PT,Update on Dengue Vaccines,
491,1408074,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408074&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzA5,3:15 PM – 3:40 PM US PT,Best Practices in the Undergraduate Classroom,
491,1408073,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408073&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzA5,3:40 PM – 4:05 PM US PT,Teaching Clinical Reasoning on the Wards & in the Clinic,
491,1408072,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408072&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzA5,4:05 PM – 4:30 PM US PT,Incorporating Clinical Reasoning into Case Conferences,
492,1408083,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408083&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTMx,3:15 PM – 3:40 PM US PT,"Burnout Lessons & Renewal, Part 1",
492,1408084,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408084&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTMx,3:40 PM – 4:05 PM US PT,"Burnout Lessons & Renewal, Part 2",
492,1408082,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408082&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTMx,4:05 PM – 4:30 PM US PT,"Burnout Lessons & Renewal, Part 3",
493,1408098,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408098&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzY1,3:15 PM – 3:40 PM US PT,Bacterial Mechanisms associated with urinary tract infection,
493,1408097,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408097&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzY1,3:40 PM – 4:05 PM US PT,Prophylactic Antibiotics in Adults with Urinary Tract Infections: Benefits and Harms,
493,1408096,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408096&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzY1,4:05 PM – 4:30 PM US PT,The Call is Coming from Inside the House: the Gut Microbiome as Reservoir for Antimicrobial Resistance,
494,1408117,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408117&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3Mzg2,3:15 PM – 3:40 PM US PT,HSV Encephalitis and Neuropathogenesis of HSV infection,
494,1408116,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408116&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3Mzg2,3:40 PM – 4:05 PM US PT,SARS-CoV-2 and Neuroimmunology,
494,1408115,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408115&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE3Mzg2,4:05 PM – 4:30 PM US PT,PML: Pathogenesis and risks in the current era of immunosuppression,
495,1498473,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498473&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY4,3:15 PM – 3:30 PM US PT,Outcomes of Military Blood Donors Screening Positive for,
495,1498469,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498469&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY4,3:30 PM – 3:45 PM US PT,"Geographic distribution of hospitalized severe malaria cases in the United States, 2012–2018",
495,1498465,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498465&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY4,3:45 PM – 4:00 PM US PT,"Evaluation of Neurocysticercosis Healthcare Provider Diagnostic Practices in Houston, Texas",
495,1498461,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498461&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY4,4:00 PM – 4:15 PM US PT,"Sustained reduction of meropenem use in a tertiary-care pediatric service in Medellín, Colombia.",
495,1498456,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498456&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY4,4:15 PM – 4:30 PM US PT,Cost-effective diagnostic algorithms for Ugandan patients with solid tumors who develop chemotherapy-associated febrile illness,
496,1498472,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498472&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY3,3:15 PM – 3:30 PM US PT,Cytomegalovirus Infections in Patients with Relapsed/Refractory Multiple Myeloma on Novel T-Cell Redirecting Therapy,
496,1498468,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498468&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY3,3:30 PM – 3:45 PM US PT,Incidence and Outcomes of Pediatric Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients Under Surveillance and Not Under Surveillance for Human Adenovirus (HAdV) in the Post-HCT Period,
496,1498464,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498464&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY3,3:45 PM – 4:00 PM US PT,Association of pre-transplant CD4 count on post-renal transplant infectious outcomes among persons with HIV,
496,1498460,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498460&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY3,4:00 PM – 4:15 PM US PT,Do Necrotizing Soft Tissue Infections Behave Differently in Patients with Hematological Malignancies? A Propensity Score-Matched Retrospective Cohort Study in an Oncological Center in Mexico City,
496,1498455,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498455&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY3,4:15 PM – 4:30 PM US PT,"Pneumonia Outcomes in Solid Organ Transplant Recipients and Patients Living with HIV: A Population-Based Study Over 20 Years (2002-2022) in Ontario, Canada",
497,1498471,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498471&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY2,3:15 PM – 3:30 PM US PT,Stable bloodstream infection rates despite rising colonization: Insights from a hospital system using in-house PCR screening for,
497,1498467,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498467&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY2,3:30 PM – 3:45 PM US PT,,
497,1498463,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498463&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY2,3:45 PM – 4:00 PM US PT,,
497,1498459,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498459&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY2,4:00 PM – 4:15 PM US PT,"A County-wide Collaboration to Drive Quality Improvement Using Healthcare-associated Infection Surveillance Data from the National Healthcare Safety Network, Centers for Disease Control and Prevention",
497,1498454,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498454&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY2,4:15 PM – 4:30 PM US PT,,
498,1498474,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498474&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY5,3:15 PM – 3:27 PM US PT,The Role of Electronic Medical Record Automation in Latent Tuberculosis Screening and Treatment in a Large Health System,
498,1498470,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498470&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY5,3:27 PM – 3:39 PM US PT,Dynamic C-PABA PET/CT Imaging for Visualizing Pulmonary Infection: Animal and Human studies,
498,1498466,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498466&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY5,3:39 PM – 3:51 PM US PT,,
498,1498462,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498462&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY5,3:51 PM – 4:03 PM US PT,"Rapid Versus Conservative Tuberculosis De-isolation Policy Impact Assessment: Province-wide Retrospective Review of 2017-2020, British Columbia, Canada",
498,1498458,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498458&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY5,4:03 PM – 4:15 PM US PT,Clinical and microbiological outcomes of omadacycline for pulmonary,
498,1498457,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498457&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjY5,4:15 PM – 4:27 PM US PT,Real-time probe-based PCR assays for the detection and surveillance of in wastewater,
502,1455412,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1455412&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDI5,8:00 AM – 8:30 AM US PT,Risk Reduction: Screening for Latent Infections Before Immunosuppression/Vaccination,
502,1455413,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1455413&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDI5,8:30 AM – 9:00 AM US PT,"Medication Safety:  Antimicrobial toxicities, Therapeutic Monitoring, and OPAT Safety",
503,1407980,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407980&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDIw,8:00 AM – 8:30 AM US PT,Clinical cases and conundrums in LAI care delivery,
503,1407981,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407981&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzNDIw,8:30 AM – 9:00 AM US PT,Clinical and qualitative insights for optimizing LAI program implementation,
504,1407991,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407991&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTI0,8:00 AM – 8:20 AM US PT,Experienced Perspectives in VPD Part 1,
504,1407993,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407993&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTI0,8:20 AM – 8:40 AM US PT,Experienced Perspectives in VPD Part 2,
504,1407992,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407992&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTI0,8:40 AM – 9:00 AM US PT,Experienced Perspectives in VPD Part 3,
505,1408013,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408013&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTc3,8:00 AM – 8:30 AM US PT,A Systematic Approach to Manuscript Appraisal,
505,1408012,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408012&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTc3,8:30 AM – 9:00 AM US PT,Your Manuscript has Comments: What Next?,
506,1408015,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408015&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTUy,8:00 AM – 8:30 AM US PT,Understanding the risk of infectious diseases at mass gatherings,
506,1408014,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408014&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTUy,8:30 AM – 9:00 AM US PT,Lessons from the Hajj and beyond,
507,1408042,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408042&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5ODAy,8:00 AM – 8:30 AM US PT,De-escalation is the Cornerstone of Stewardship,
507,1408043,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408043&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5ODAy,8:30 AM – 9:00 AM US PT,Spectrum De-escalation: Is the experiment over?,
508,1408077,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408077&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2MzU5,8:00 AM – 8:30 AM US PT,Top Research Papers: Molds and Dimorphic Fungi,
508,1408078,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408078&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE2MzU5,8:30 AM – 9:00 AM US PT,Top Research Papers: Yeasts,
509,1408086,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408086&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTI2,8:00 AM – 8:30 AM US PT,New developments in the diagnosis of tick-born infections,
509,1408085,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408085&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTI2,8:30 AM – 9:00 AM US PT,Coming approaches in the treatment and prophylaxis of tick-borne infections,
510,1408089,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408089&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE4OTgx,8:00 AM – 8:30 AM US PT,Review of infection prevention strategies for HCT and CAR-T cell therapy recipients,
510,1408090,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408090&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE4OTgx,8:30 AM – 9:00 AM US PT,Review of management strategies for SOT recipients,
511,1408118,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408118&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEwMjMy,8:00 AM – 8:30 AM US PT,Clinical Deployment of Novel Multiplex Panels,
511,1408119,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408119&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEwMjMy,8:30 AM – 9:00 AM US PT,Future Directions for Multiplexed Infectious Disease Panel Testing,
512,1423427,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1423427&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDY0MjQ2,9:15 AM – 9:35 AM US PT,Awards Presentation,N/A
512,1500711,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1500711&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDY0MjQ2,9:35 AM – 10:00 AM US PT,Presentation TBD,
513,1407862,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407862&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTYz,10:30 AM – 10:55 AM US PT,Emerging Zoonotic Viruses,
513,1407866,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407866&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTYz,10:55 AM – 11:20 AM US PT,Climate Change and Emerging Infectious Diseases- A Clinical Approach,
513,1407861,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407861&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTYz,11:20 AM – 11:45 AM US PT,Developing Diagnostics for Emerging Infections,
514,1407903,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407903&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTM4,10:30 AM – 10:55 AM US PT,Optimizing Public Health through OPAT,
514,1407902,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407902&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTM4,10:55 AM – 11:20 AM US PT,Strategies for designing equitable OPAT programs,
514,1407901,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407901&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTM4,11:20 AM – 11:45 AM US PT,The Future is at Home,
515,1407960,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407960&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzY2,10:55 AM – 11:20 AM US PT,The Use of Host-Directed Therapy to Address Tuberculosis,
515,1407959,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407959&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzY2,11:20 AM – 11:45 AM US PT,Host-Directed Therapy in Fungal Diseases,
515,1407961,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407961&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDE5NzY2,11:30 AM – 10:55 AM US PT,Host-Directed Interventions Against Malaria,
517,1407988,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407988&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTcx,10:30 AM – 10:55 AM US PT,Therapy for patients with complex pulmonary syndromes such as empyema,
517,1407989,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407989&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTcx,10:55 AM – 11:20 AM US PT,Therapy for UTIs in Kidney Transplant Recipients and Other Vulnerable Patients,
517,1407990,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1407990&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTcx,11:20 AM – 11:45 AM US PT,Therapy for invasive candidiasis,
518,1408039,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408039&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTgy,10:30 AM – 10:55 AM US PT,No Time to Lues: Evaluation & Management of Congenital Syphilis in the Exposed/Infected Infant,
518,1408037,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408037&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTgy,10:55 AM – 11:20 AM US PT,Care of Infants with Inadequate Maternal Prenatal Care,
518,1408038,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1408038&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMTgy,11:20 AM – 11:45 AM US PT,Preventing Congenital Syphilis by Addressing Missed Opportunities in Pregnancy,
519,1424516,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424516&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzEx,10:30 AM – 10:55 AM US PT,New HCV diagnostics & decentralization of HCV testing and treatment,
519,1424514,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424514&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzEx,10:55 AM – 11:20 AM US PT,Further simplification of HCV treatment,
519,1424518,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1424518&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDEyMzEx,11:20 AM – 11:45 AM US PT,"Integrating POC HCV RNA testing into mobile, syringe services, opioid treatment, and other high-impact programs",
520,1405689,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1405689&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA1NjQ3,10:30 AM – 10:55 AM US PT,Mask or Not to Mask: Approaches to Source Control During Respiratory Virus Season in Acute Care Hospitals,
520,1405685,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1405685&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA1NjQ3,10:55 AM – 11:20 AM US PT,"Little patients, big changes: Strategies to implement the 2024 NHSN Pediatric HAI Definitions",
520,1405688,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1405688&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDA1NjQ3,11:20 AM – 11:45 AM US PT,Using Carrots Instead of Sticks: How Policy Makers Can Promote IPC Practices in LTC,
521,1498314,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498314&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc3,10:30 AM – 10:45 AM US PT,Seeing the full picture: Adding discharge antibiotic durations to the dashboard,
521,1498310,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498310&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc3,10:45 AM – 11:00 AM US PT,Finding AP Gap: An Assessment of Antibiotic Use in Acute Pancreatitis,
521,1498306,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498306&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc3,11:00 AM – 11:15 AM US PT,Impact of Implementation of World Health Organization (WHO) National Action Plans (NAP) on Antibiotic Rates: A Time Series Analysis of 38 Countries,
521,1498302,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498302&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc3,11:15 AM – 11:30 AM US PT,Epidemiology and Outcomes of Broad-Spectrum Antibiotic De-escalation in Patients with Suspected Sepsis in US Hospitals,
521,1498297,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498297&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc3,11:30 AM – 11:45 AM US PT,Antibiotic Mobile Application ABxSG - An Innovative and Effective Antibiotic Stewardship Tool that Improves Antibiotic Use and Reduces Healthcare Costs,
522,1498313,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498313&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc1,10:30 AM – 10:45 AM US PT,Missed opportunities for HIV Prevention and Treatment in People Hospitalized with Serious Injection Related Infections: The CHOICE+ Cohort,
522,1498309,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498309&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc1,10:45 AM – 11:00 AM US PT,,
522,1498305,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498305&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc1,11:00 AM – 11:15 AM US PT,Week 26 Interim Analysis of Implementation and Delivery of Long-Acting Injectable Cabotegravir for PrEP in a Community Pharmacy Setting,
522,1498301,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498301&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc1,11:15 AM – 11:30 AM US PT,,
522,1498296,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498296&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc1,11:30 AM – 11:45 AM US PT,"Cabotegravir Long-Acting for Pre-Exposure Prophylaxis (PrEP): Real World Data on On-Time Dosing, HIV Testing and HIV Acquisition from the OPERA Cohort",
523,1498315,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498315&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc4,10:30 AM – 10:42 AM US PT,-specific CRISPR-Cas3 bacteriophage cocktail developed to treat respiratory and bloodstream infections,
523,1498311,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498311&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc4,10:42 AM – 10:54 AM US PT,Bacteriophages as Drug Delivery Vehicles for Polymyxin B,
523,1498307,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498307&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc4,10:54 AM – 11:06 AM US PT,Activity of Sulbactam-durlobactam and Standard-of-Care Antibiotics complex isolates acquired from Hospitalized Patients in the United States (2023 – 2024),
523,1498303,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498303&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc4,11:06 AM – 11:18 AM US PT,Efficacy of Gepotidacin versus Nitrofurantoin in a Nitrofurantoin Not Susceptible Population: A Pooled Analysis of the EAGLE-2 and EAGLE-3 Randomized Controlled Trials in Uncomplicated Urinary Tract Infection,
523,1498299,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498299&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc4,11:18 AM – 11:30 AM US PT,Cefiderocol Retains Activity Against Enterobacterales Non-Susceptible to ?-lactam-?-lactamase Inhibitor Combinations,
523,1498298,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498298&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc4,11:30 AM – 11:43 AM US PT,The Impact of Xeruborbactam on Activity of Cefiderocol against a Panel of Enriched in Isolates with Reduced Cefiderocol Susceptibility,
524,1498312,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498312&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc2,10:30 AM – 10:45 AM US PT,"Neurological Complications in Children Hospitalized for Influenza, 2010 to 2022, the Canadian Immunization Monitoring Program Active (IMPACT)",
524,1498308,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498308&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc2,10:45 AM – 11:00 AM US PT,Cytomegalovirus (CMV) Saliva Shedding Kinetics in Children with Congenital Cytomegalovirus Infection (cCMV).,
524,1498304,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498304&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc2,11:00 AM – 11:15 AM US PT,,
524,1498300,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498300&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc2,11:15 AM – 11:30 AM US PT,Newborn immune transcriptome changes rapidly and is shaped by maternal SARS-CoV-2 infection and/or vaccination,
524,1498295,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498295&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMjc2,11:30 AM – 11:45 AM US PT,Antibodies Produced by Children with Kawasaki Disease (KD) Consistently Recognize Antigen in KD Tissues from the US and Japan,
527,1498257,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498257&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE4,12:15 PM – 12:20 PM US PT,"Previously Diagnosed, Untreated Hepatitis C Among Emergency Department And Urgent Care Patients",
527,1498254,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498254&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE4,12:20 PM – 12:25 PM US PT,Efficacy and safety of buleviritide monotherapy for chronic hepatitis D in patients with and without cirrhosis: results from the week 144 interim analysis of a phase 3 randomized study,
527,1498251,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498251&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE4,12:25 PM – 12:30 PM US PT,The Integration of Hepatitis C Treatment into Rural Syringe Services Programs via Telehealth: A Highly Effective Care Model,
527,1498248,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498248&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE4,12:30 PM – 12:35 PM US PT,,
527,1498245,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498245&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE4,12:35 PM – 12:40 PM US PT,Active Surveillance of Mucosal Pneumococcal Infections to Predict the Potential Added Benefits of Extended-Spectrum PCVs in Children < 24 Months in Southern Israel,
527,1498242,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498242&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE4,12:40 PM – 12:45 PM US PT,Culture Positive Pneumococcal Pneumonia Requiring Hospital Admission from 2017-2022 at Eight US Children’s Hospitals,
528,1498453,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498453&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE1,12:15 PM – 12:45 PM US PT,,
528,1498452,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498452&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE1,12:15 PM – 12:45 PM US PT,A febrile illness in pregnancy,
528,1498451,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498451&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE1,12:15 PM – 12:45 PM US PT,An unusual joint infection,
528,1498450,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498450&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE1,12:15 PM – 12:45 PM US PT,"Fevers, bilateral hearing loss, and altered sensorium in a patient with acute myeloid leukemia following induction chemotherapy",
528,1498449,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498449&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE1,12:15 PM – 12:45 PM US PT,Neonatal Meningitis: Difficult Microbial Identification and Severe Sequelae,
529,1498256,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498256&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE3,12:15 PM – 12:20 PM US PT,Assessing The Impact of an Electronic Health Record Embedded Treatment Algorithm and Order Set on Antipseudomonal Antibiotic Use in Diabetic Foot Infections,
529,1498253,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498253&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE3,12:20 PM – 12:25 PM US PT,Artificial Intelligence Modeling and Implementation in Antimicrobial Stewardship Program at a Tertiary Medical Center in Taiwan,
529,1498250,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498250&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE3,12:25 PM – 12:30 PM US PT,Assessing the Impact of Reflex Urine Cultures in Pediatrics,
529,1498247,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498247&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE3,12:30 PM – 12:35 PM US PT,Clinical Microbiology of Xylazine-Associated Wound Infections,
529,1498244,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498244&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE3,12:35 PM – 12:40 PM US PT,Factors affecting vancomycin and piperacillin/tazobactam-induced nephrotoxicity,
529,1498241,http://local.dev.meetings.com/IDWEEK/_viewSessionData.cfm?thisID=/ajaxcalls/PresentationInfo.asp?PresentationID=1498241&returl=YWpheGNhbGxzL3Nlc3Npb25pbmZvLmFzcD9QcmVzZW50YXRpb25JRD0xNDIzMzE3,12:40 PM – 12:45 PM US PT,Digital Five-Step Tool Enhances Standard Perioperative Prophylaxis by Delabeling Surgical Patients from Allergy to Beta-Lactam Antibiotics,
